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Abstract 
Single-stranded RNA and DNA aptamers have been developed in order to selectively inhibit 
specific biological targets. The tridimensional structural arrangement of aptamers guarantees their 
selective and specific binding to the target. A large number of G-rich aptamers are able to form G-
quadruplex (G-4) structures. The high polymorphism of G-4 structure provides for a range of stable 
structures having specific recognition sites on the corresponding target. Several aptamers based on 
the G-4 structures are attractive tools for the detection and treatment of vascular, cancer and viral 
diseases, many of which are currently being tested in preclinical and clinical trials.  
Often, in order to increase the in vivo nuclease aptamer resistance and/or to elucidate the aptamer-
target structure-activity relationships, the initial aptamers, obtained by SELEX (Systematic 
Evolution of LIgands by EXponential enrichment), are subjected to chemical modifications. In this 
context, a piece of my research activity has been centred on the synthesis of modified G-quadruplex 
forming aptamers endowed with potential pharmacological activities. 
In order to explore the potential of the TBA G-quadruplex as antiproliferative agent, I searched for 
that TBA single residue modification capable both to turn off the antithrombin activity and to 
preserve the aptamer antiproliferative action. I reached this goal modifying the TBA with a 
particular biphenyl linker that was used instead of T residue at position 3, 4, 7, 9, 12 or 13. Each of 
six TBA variants was studied from structural point of view by CD, CD melting, 1 and 2D NMR 
techniques. The acquired data demonstrated that almost all the sequences were able to fold into 
monomolecular “chair-like” G-Quadruplex structure, strongly similar to that of TBA. On the other 
hand, the results of biological studies showed that two TBA variants, containing the modification at 
T4 or T13, lacked of the TBA antithrombin activity but preserved the TBA antiproliferative activity 
on He-La cells. Results concerning this research are discussed in the chapter 2, part I. 
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Another G-quadruplex forming aptamer, named T30695 was been chemically modified at T-loop 
residues. T30695 has been selected as HIV-Integrase (HIV-In) inhibitor and its biological action is 
today still ambiguous. In fact, the T30695 virus inhibition is also connected with the binding to 
Gp120. The formation of T30695-Gp120 complex impairs the host-viral interaction and thus 
reduces the infectivity of HIV. Furthermore, in view of the results of recent studies on the G-
quadruplex T30695 typology, such previously reported T30695-HIV-In structure-activity 
relationships require to be revised. A part of my studies has been performed to acquire new 
information about T30695 anti-HIV-In activity. In particular, I synthesised a new set of modified 
T30695 aptamers in which single T residue at position 4, 8 or 12 was modified as R or S glycerol T. 
Structural studies on modified aptamers, performed using CD, CD melting, EMSA, HRMS and 1H 
NMR, highlighted that almost all modified sequences were able to form the same G-Quadruplex 
typology of that of T30695. LEDGF-p75 dependent and independent integration assays provided 
information about the biological behaviour of the modified aptamers. The results of these studies 
are described in the chapter 3, part I. 
During the third year of my PhD course I have focused my studies on the synthesis of azobenzene 
photowitchers useful both as antiproliferative agents and as modifying units of conjugated 
aptamers. Some newly synthesized chiral azo-heteroarenes showed promising photo-regulated 
antiproliferative activity on HCT116-p53-/- cancer cells. Results concerning the synthesis, the 
structural characterization and the biological behaviours of these new molecules are described in the 
chapter 2, part II. 
Finally, I carried out the synthesis of 1-(4-dimethyaminobenzyl)-2-(4'-(R-2,3-
dihydroxypropoxy))diazobenzene as phosphoramidite building block useful to obtain 5'-conjugated 
oligonucleotides. I performed the conjugation of the synthesized building block at 5'-end of the 
TBA and of the T30695 aptamers. Preliminary spectroscopic studies concerning the behaviour of 
conjugated aptamers under photo-illumination are reported in chapter 3, part II. 
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Part I 
1. Introduction 
1.1. Aptamers and SELEX  
Aptamers (from the Latin “aptus” meaning “to fit”) are short, single-stranded DNA or RNA 
oligonucleotides, that, through specific three dimensional structures, bind with high affinity and 
specificity to a large variety of molecular targets [1][2]. Most of aptamer-target complexes show 
dissociation constants in the picomolar to nanomolar range. Several chemical and biological 
properties make aptamers suitable for a growing number of therapeutic and diagnostic applications 
[3][4]. Notably, the use of aptamers instead of antibodies have many important advantages, such as: 
 High thermal stability, most of discovered aptamers preserve their tertiary structure over 
many cycles of denaturation/renaturation; 
 Low immunogenicity, oligonucleotides are not identified by the human immune system as 
foreign agents; 
 Aptamers can be synthesized with high reproducibility and low production costs. Moreover, 
they can be easily subjected to different types of post-synthetic modification, in order to 
increase their in vivo life time; 
 The low molecular weight makes aptamers capable to penetrate the tissue barriers better 
than antibodies. 
Aptamers are isolated from 1012–1015 combinatorial oligonucleotide libraries through a technique 
known as SELEX (Systematic Evolution of Ligands by EXponential enrichment)[1][2]. The SELEX 
process relies on three steps (Figure 1): in the initial stage (library generation) a large library of 
single-stranded oligonucleotide templates, consisting of random sequence regions, usually 30–40 
mers, is obtained from integrated DNA Technologies. The 5’-and 3’- terminal sequences are fixed 
for the primer binding. In the second stage (binding and separation) firstly the sequences of the 
library are exposed to the target-ligand, than the unbound components are removed using a 
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partitioning method. At last, in the third stage (amplification) the target-bound sequences are eluted 
and amplified by PCR in order to be used for the next rounds of incubation, separation, and 
amplification. The complete SELEX process generally comprises of 7-15 rounds of selection 
discovering a small number of aptamers having high affinity and specificity toward the target 
(Figure 1)[5]. 
 
Figure 1. SELEX (Systematic Evolution of Ligands by EXponential enrichment). 
 
1.2. G-quadruplex  
G-rich DNA or RNA aptamers are able to adopt such particular spatial arrangements called G-
quadruplex (G-Q) structures, arising from the stacking of a certain number of G-quartets. Each G-
quartet consists of four guanine bases cyclically connected to each other through Hoogsteen 
hydrogen bonding (Figure 2) [6]. 
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Figure 2. Hydrogen-bonding between bases and metal ion coordination in a G-quartet. 
 
A large number of GQ typologies have been structurally characterized by means of NMR or X-Ray 
techniques, thus evidencing a high structural GQ polymorphism [7][8]. Particularly, GQs can arise 
from one, two or four single stranded oligonucleotides and, consequently can be unimolecular 
(intramolecular), bimolecular (dimeric) and tetramolecular (tetrameric). Generally, a potential 
unimolecular GQ has the following sequence: 
GmXnGmXoGmXpGm 
m represents the number of G residues forming the G-tracts, while Xn, Xo and Xp are the residues 
being part of the loops.  
Almost all bimolecular structurally characterized GQs involve the association of two identical 
sequences XnGmXoGmXp, in which n and p, namely, the number of residues separating the G-
tracts (Gm), may or may not be zero. Four XnGmXo or GmXnGm strands can associate to form 
tetramolecular GQs.  
Furthermore, into monomolecular and bimolecular GQs, the phosphate backbone polarity of G-
tracts can be parallel or anti-parallel thus originating parallel or antiparallel GQs and affecting the 
relative orientations and the localizations of the loops. Some examples are shown in the figure 3. In 
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a parallel bimolecular GQs (Figure 3a), the loops, that connect two G-tracts, in each single stranded 
oligonucleotides, should link the bottom G-tetrad with the top one, leading to a particular spatial 
arrangement called propeller-type (double-chain-reversal loop). Into the anti-parallel bimolecular 
GQs the two G-tracts of each strand can be linked either by diagonal or lateral (edgewise) loops 
(Figure 3b and 3c). 
 
Figure 3. Schematic diagrams of the (a) parallel, (b) lateral and (c) diagonal loop of dimeric GQs. 
 
Additionally, the GQ lateral loops can be classified as head-to-head or head-to-tail. In the first type, 
loops are located on the same GQ face; conversely, in the latter type they are located on the 
opposite GQ faces. Further important GQ features are related to the glycosidic torsion angles 
assumed by the guanine residues forming the GQ core (Figure 4); guanine residues forming parallel 
GQs are preferentially in the conformation anti, while they alternatively assume the syn and anti 
conformations in the case of anti-parallel GQs (Figure 4). 
 
 
 
Figure 4. Guanine glycosidic angles in syn and anti conformations. 
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Most importantly, the overall GQ structure is stabilized by different type of cations, especially 
potassium cations. Generally, the monovalent cations occupy the negative charged central cavities 
of the G-quadruplex core coordinating the guanine O6 oxygen atoms and thus reducing the strong 
negative electrostatic potential of the inner cavity of the GQ core [7-10] (Figure 5). Inner the GQ-
core, the relative location of the cations respect to the stacked G-quartets depends on the nature of 
the ion; the small Na+ ions preferentially coordinate the four O-6 of the same G-quartet, occupying 
the inner cavity of each G-quartet; being their radius more higher than that of Na+, K+ ions are 
centred between two G-quartets, coordinating the eight O-6 atoms of the two G-quartets in a 
symmetric tetragonal bipyramidal configuration [11] (Figure 5).  
 
 
 
Figure 5. Location of the cations respect to the stacked G-quartets. (A) Parallel stacked quartets with Na+ stabilization (purple 
spheres) from (d(TGGGGT)4), (B) parallel stacked quartets with K+ stabilization (green spheres) from (dA(GGGTTA)3GGG), (C) 
d(TGGGGT)4stacking in space filling representation, (D) dA(GGGTTA)3GGG stacking in space filling representation [from Nucleic 
Acids Res., vol. 36, no. 17, pp. 5482–5515, 2008]. 
 
The majority of the studies have been centred on the evaluation of the influence of Na+ or K+ on the 
GQ structure stability and typology; however, several other monovalent and divalent ions are able 
to influence the G-Q structure futures, including the monovalent cations Rb+, Cs+,NH4
+, and Tl+ and 
divalent cations Sr2+, Ba2+, and Pb2+[9].  
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Cations play a critical role in stabilizing G-quadruplex structures in the following order: K+> Ca2+> 
Na+> Mg2+> Li+ and K+> Rb+> Cs+ [12]. In addition, the GQ typology and/or GQ conformations 
can also depend on the type of cations used in the solution. Although some general trends are 
evident (i.e. potassium can promote parallel conformations)[13], the prediction of the possible GQ 
typologies, raised from a certain sequence, is not obvious, and it requires to be characterized 
empirically under different folding conditions. 
Guanine-rich sequences spread along the genome of most organisms, especially at the ends of 
chromosomes, named telomeres [14]. They consist of such simple motifs repeated in tandem. 
Human telomeres consist of the hexanucleotide d(TTAGGG)n 5–10 kb length, that terminate in a 
single-stranded 3′-overhang of 35–600 bases. This motif was found also in other regulatory regions, 
specifically in the immunoglobulin switch regions and in the promoter of the c-myc oncogenes [15].  
After 20–40 replication cycles telomeres are progressively shortened until cells death is induced. 
This mechanism is closely related to the cellular immortality; indeed, immortalized cells preserve 
the length of their telomeres during an unlimited number of cell cycles. In this frame, an RNA-
dependent DNA polymerase enzyme, named telomerase, acts to preserve telomere length and 
integrity, thus playing an important role in tumorigenesis. Several studies suggested that the folding 
of telomeric DNA into GQs can decreases the enzymatic activity of telomerase, thus reducing 
cancer cell survival [16]. In this context, notable efforts are now performing in order to discover 
new anticancer drugs able to bind and to stabilize telomeric GQs. Some discovered GQ targeting 
drugs are reported in figure 6 [17-22]. 
Actually the G-quadruplex-targeting drug, quarfloxacin® (CX-3543, Cylene Pharmaceuticals in 
San Diego, CA, USA) (Figure 6a) has showed an excellent in vivo activity in various solid tumors 
and is ongoing the Phase II clinical trials. Quarfloxin arises from the design of G-quadruplex-
interactive fluoroquinolones [23], a class of duplex DNA–gyrase or DNA–topoisomerase II 
complexes targeting drugs. Quarfloxin targets selectivity GQs in rDNA-respect to duplex or single-
stranded DNA and it is also selectively internalized into the nucleolus of cancer cells [23][24]. 
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Figure 6. G-quadruplex-targeting drugs [from Futur. Med. Chem., vol. 2, no. 4, pp. 619–646, 2010]. 
 
In order to explore new potential GQ-based cancer therapy, the researchers are now focused on the 
discovered of new ligands for GQs, but also on the physical and biological characterization of 
different GQ-forming aptamers that have shown very interesting anticancer properties. The first part 
of my research activity was centred on the latter field and has been developed through the synthesis 
and the structural characterization of new TBA analogues useful as antiproliferative agents. The 
background and the results of this activity will be discussed in the next chapter. 
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2. DNA Aptamers as potential antiproliferative agents  
2.1. Site specific replacements of a single loop nucleoside with a dibenzyl linker may switch 
the activity of TBA from anticoagulant to antiproliferative 
Currently cancer is the leading cause of death all over the world. Although the therapies now 
available increase the life expectancy, on the other hand, significantly produce serious side effect 
arising from the lack of selectivity towards cancer cells. Importantly, a right prognosis corresponds 
with shorter detection and diagnosis timelines, for this reason the discovery of new biomarkers that 
are specific to particular cancers is crucial in the field of cancer biology. Clearly there is an urgent 
need for further cancer therapies to improve efficacy and selectivity against cancer cells, and 
disease-specific biomarkers for the recognition of proteins, or other biological molecules that 
distinguish between normal and malignant cells. In this context nucleic acid aptamers have been 
identified as very promising therapeutic and diagnostic agents, drawing the attention in the cancer 
research. The ability of aptamers to fold into secondary and tertiary structures allow to bind 
selectively a wide range of targets through a shape-specific recognition. 
Many G-rich oligonucleotides (GROs), forming G-quadruplex structures, have shown the ability to 
inhibit the cancer cells growth, among them the most advanced in preclinical and clinical studies is 
a 26-mer sequence (5’-GGTGGTGGTGGTTGTGGTGGTGGTGG), formerly developed by 
Aptamera as AGRO100, then as AS1411 after acquisition by Antisoma in 2005, and currently in 
Phase II clinical trials. AS1411 was developed from observations based on antiproliferative 
properties on cancer cells of some G-rich oligonucleotides. The antiproliferative activity of these 
GROs (such as the 29-mer GRO29A; 5’-TTTGGTGGTGGTGGTTGTGGTGGTGGTGG-3’with a 
3’ aminoalkyl modification) was associated with their ability to form stable G-quadruplex [25][26] 
and their biological activity was correlated with binding to a specific protein, known as nucleolin 
[25]. Additional studies showed that some analogues, including an unmodified DNA 
phosphodiester oligonucleotide (GRO29A-OH), were stable in serum-containing medium and thus 
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resistant to nuclease degradation [27], consequently AS1411 arose from the considerations that the 
3′-modification was not required for either nuclease resistance or activity [27] and that the 5′-
terminus “tail” (5′-TTT) of GRO29A was not essential for activity [28][29].  
AS1411 displayed antiproliferative activity in huge number of cancer cell lines, proving such a 
tumor-selectivity [29][30]. 
AS1411 growth-inhibitory was dependent on the time course [28]; specifically when AS1411 was 
added to cells, cell division was inhibited and the induction of cell death occurred only after 
prolonged exposure (2–4 days, depending on the cell line). 
Actually, AS1411 proceeds through Phase II clinical trials, but many questions about the activity 
and mechanism of action of GROs remain incomplete. In early studies the biological activities of 
GROs seemed to be depending on quadruplex formation and a specific GRO-protein binding [31]. 
The GROs molecular target was considered to be nucleolin, a multifunctional protein involving in 
many cellular processes, such as ribosome biogenesis, DNA replication, transcription, translation, 
chromatin remodelling, apoptosis, cytokinesis, protein trafficking and telomere maintenance 
[27][32].Although nucleolin was considered mainly a nucleolar protein, its functions as a cell 
surface receptor and as a shuttling protein between cytoplasm and nucleus were reported [33]; 
furthermore it was found overexpressed in cytoplasm and on the cell surface of many cancer cells 
[30]. According to the ability of nucleolin to play a role in the endocytosis of many ligands, 
nucleolin-mediated cellular uptake mechanism for AS1411 was initially proposed. Further studies 
showed that the initial uptake of AS1411 occurs through macropinocytosis and that a subsequent 
abnormal nucleolin stimulated macropinocytosis (24–72 h after addition) led to the additional 
cancer-selective uptake of the aptamer [34]. 
Additionally, AS1411 has been found to inhibit many functions involving the nucleolin [28][35], 
but the exact role of nucleolin and the real mechanism of action of AS1411 haven’t been clarified. 
After all in further studies the antiproliferative activity of GROs seemed to be attributed to the 
cytotoxicity of their guanosine-based degradation products [36].  
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While it is reasonable to suppose that GROs can target cancer cells through different pathways, 
poor information, if any, about the structure-activity relationships (SARs) between G-quadruplex 
typologies and protein interactions are available. Indeed, almost all anticancer GROs are 
characterized by a high grade of structural polymorphism [37][38]. They form in solution several 
G4 structures differing for the molecularity and/or loop arrangement [39]. Therefore, the possibility 
to fully understand the SAR of each oligodeoxynucleotide (ODN) is definitely subject to the 
availability of biologically active sequences forming single and well-defined G-quadruplex 
structures. 
Interestingly, a cell-based screening of several GROs demonstrated that the GT-rich 15-mer 
ODN,TBA (thrombin binding aptamer G2T2G2TGTG2T2G2, an ODN binding and inhibiting 
thrombin) [40-42], possesses a significant antiproliferative activity [43]. Moreover, an 
electrophoretic mobility shift assay showed that TBA, like AS1411, is able to bind to a nucleolar 
protein, thought to be nucleolin [43]. A powerful correlation between the stability of the TBA 
tertiary structure and the two related functional effects has been shown as well. Both the 
anticoagulant [44] and the antiproliferative efficiencies [43] of TBA are enhanced in the presence of 
K+ ions, which are known to promote and stabilize the structuration of TBA into a monomolecular 
chair-type antiparallel G-quadruplex. 
Additionally, recently reported data suggested that antiparallel G-quadruplex forming ONs, 
including TBA, accumulate into mitochondria of CL1–0 living cells [45].  Into this cellular district, 
G4 structures could occur to regulate some essential events [46][47]. In particular, it has been 
shown that NOA1, a large GTP binding protein [48], binds some parallel and antiparallel G-
quadruplex forming ONs [49]. Unfortunately, the potential of the TBA G4 as a molecular tool in 
cancer research is strongly limited by its high affinity to thrombin and to most of the thrombin 
precursors [50]. Still, since no connection between anticoagulant and antiproliferative activities is 
apparent, different TBA regions and/or different binding mode with its biological targets are most 
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likely involved, thus giving the opportunity to perform SAR studies of the two biological effects 
separately.  
 
2.2. Results 
In the quest for new TBA analogues endowed with increased antiproliferative activity, it is not 
unreasonable to start investigating chemical modifications of TBA sequence that, safeguarding the 
G4 tertiary structure, selectively quench its anti-thrombin activity. In the light of this reasoning and 
of the literature data concerning the TBA/thrombin interaction [41][42] and the related SARs, [51-
53] we have synthesized a pool of seven new 15-mer TBA analogues (TBA-bs) (Table 1), each of 
them containing a dibenzyl linker replacing one nucleoside in the loop regions. The new TBA 
analogues were investigated for their structural and biological properties. CD and NMR 
measurements indicated that most of the new analogues were able to fold into monomolecular 
‘chair-like’ G4s very similar to that adopted by the TBA. Biological results obtained by performing 
the fibrinogen, prothrombin time (PT) and Methylthiazol Tetrazolium (MTT) tests, indicated that 
two out of the seven derivatives (TBA-bs4 and TBA-bs13) lost the antithrombin and anticoagulant 
activities but preserved (TBA-bs4) or enhanced (TBA-bs13) the antiproliferative activity with 
respect to the TBA. The NMR based molecular model of the G4 formed by TBA-bs13 suggested 
that the dibenzyl linker could obstruct the binding of TBA-bs13 to thrombin, by steric hindrance in 
the inner region delimited by the TT loops, thus determining the exclusive switch of the biological 
activity toward the antiproliferative one. 
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Table 1. TBA-based sequences (TBA-bs) containing 2,2-dibenzylpropane-1,3- diol (X) at the indicated position 
 
ON Sequence 
TBA G1G2T3T4G5G6T7G8T9G10G11T12T13G14G15 
TBA-bs3 G1G2×3T4G5G6T7G8T9G10G11T12T13G14G15 
TBA-bs4 G1G2T3×4G5G6T7G8T9G10G11T12T13G14G15 
TBA-bs7 G1G2T3T4G5G6×7G8T9G10G11T12T13G14G15 
TBA-bs8 G1G2T3T4G5G6T7×8T9G10G11T12T13G14G15 
TBA-bs9 G1G2T3T4G5G6T7G8×9G10G11T12T13G14G15 
TBA-bs12 G1G2T3T4G5G6T7G8T9G10G11×12T13G14G15 
TBA-bs13 G1G2T3T4G5G6T7G8T9G10G11T12×13G14G15 
 
X = 2,2-dibenzylpropane-1,3-diol. 
Synthesis of ONs 
The synthesis of derivative 3 (Figure 7) started from the commercially available 2,2-
dibenzylpropane-1,3-diol 1, that was subjected to the standard protection of one alcoholic function 
with 4,4′-dimethoxytrityl group. The protected product 2was then reacted with β-cyanoethyl-N,N’-
diisopropyl-chloro-phosphoramidite to obtain 3. This monomer was used to automatically 
synthesize the modified ONs reported in Table1using the standard phosphoramidite protocol[54]. 
The length of the coupling cycle using the new monomer 3 was extended from 2 min to 10 min. The 
yields of coupling were similar to those obtained using the standard phosphoramidite building 
blocks. 
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Figure 7. Synthesis of phosphoramidite building block. i) 2,2-dibenzylpropane-1,3- diol 1 (2.0 g, 7.8 mmol), 4,4-dimethoxytrityl 
chloride (1.32 g, 3.9 mmol), 4-dimethylaminopyridine (2.0 × 10−2 g, 0.16 mmol) dry Py (5.0 ml), 2.5 h, yields 40%; ii) 2 (1.0 g, 1.8 
mmol),β-cyanoethyl-N,N’-diisopropyl-chloro-phosphoramidite (0.450 ml, 1.8mmol), DIPEA (0.350 ml, 3.6 mmol), dry DCM (3.5 
ml), 1.0 h, 85%. 
 
CD and CD melting 
The folding of TBA into the monomolecular antiparallel chair-like G-quadruplex structure causes a 
well-known CD profile characterized by three positive bands at 212, 247 and 295 nm and a negative 
band around 270 nm [55]. Indeed, CD spectroscopy is commonly used to quickly valuate the effects 
of sequence modifications on the general feature of TBA G-quadruplex [56]. To this purpose we 
performed CD analyses both in PBS (Figure 8) and K+ buffer. From collected data it appears that 
almost all new ONs in both used buffers fold into structures that display a CD profile very close to 
that of TBA. However, in some cases slight differences in the profile or in the intensity of bands 
were revealed. To analyse these effects as a function of the position occupied by dibenzyl linker 
along the sequence, the collected data were divided into two sets. 
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Figure 8. CD profile of TBA and TBA-based sequences. Spectra were collected at 10°C, using [ON] of 2.0×10−5 M in PBS buffer. 
 
According to NMR and X-ray data, that designate the residues at position 4, 8, 9 and 13 as essential 
for the topology and the stability of the G4 structure, we grouped the CD profiles of the 
corresponding TBA-bs variants in figure 8, panel A. Notably, the CD spectra of TBA-bs8 and TBA-
bs9 showed a significant decreasing in the intensity of the CD band at 292 nm, compared to that of 
TBA. Furthermore, the spectra of the variants (Figure 8a) containing the linker 1 at position 4 or 9 
or 13 were strongly similar to each other and slightly differed from that of TBA by a more negative 
CD signal in the range 230–270 nm. 
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The CD spectra of TBA-bs modified at position 3 or 7 or 12 are shown in figure 8, panel B. All the 
variants in this group preserved almost unchanged the CD profile of TBA. The only difference we 
observed was a slight decrease in the intensity of the positive CD bands for TBA-bs3 and TBA-bs7. 
To evaluate the thermal stability of the folded G-quadruplexes we performed CD melting 
experiments. The melting curves were registered monitoring the change of the intensity of the band 
at 295 nm increasing the temperature from 10°C to 90°C (Figure 9). The derived apparent melting 
temperatures (Table 2) indicated that the thermal stability of TBA-bs4 and TBA-bs13 G4s was 
slightly higher than that measured for TBA (ΔTm∼3–4°C in both PBS and K+ buffer) whereas that 
of TBA-bs3, TBA-bs7 and TBA-bs12 was almost unchanged. In contrast, TBA-bs8 and, especially, 
TBA-bs9 folded into G4s considerably less stable than that of TBA in both K+ buffer (ΔTm -4.3 and 
-15.5°C, respectively) and PBS. Furthermore, in the case of TBA-bs9, as a result of the poor 
structure stability in PBS, it was not possible to calculate the melting temperature from the 
corresponding melting curve. 
Finally, to probe the molecularity of the G-quadruplexes, all the CD melting experiments in K+ 
buffer were also performed on samples at the two additional strand concentrations of 1.0 × 10−4and 
8.3 × 10−6M (12-fold relative dilution). For all TBAs, we did not observe significant differences 
between the two sets of melting profiles thus suggesting that the modified ONs preserve the ability 
of TBA to fold into monomolecular G4s [57]. 
 
18 
 
 
Figure 9. CD melting profiles of TBA and TBA-based sequences. Fixed wavelength 295 nm, [ON] of 2.0×10-5 M. Cell length 0.5 
cm. Temperature scan speed 0.5 °C/min. a. PBS. b. K+ buffer. Lines: black TBA; red TBA-bs8; green TBA-bs9; fuchsia TBA-bs4; 
blue TBA-bs13. c. PBS. d. K+ buffer. Lines: black TBA; blue TBA-bs3; green TBA-bs7; red TBA-bs12. 
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Table 2. Thermal stability and biological properties of TBA and TBA-based sequences. The apparent melting temperatures (◦C) were 
measured as minimum in the first derivative of CD melting profiles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aAnnealing buffer: 90 mM KCl, 10 mM potassium phosphate, pH 7.4. 
bCalculated respect to TBA melting temperature. 
cAnnealing buffer: PBS, pH 7.4. 
dRatio between measured absorbance in MTT test in presence and in absence of ONs. 
eStandard Deviation. 
fMeasured Prothrombin Time in human plasma. 
gStandard Error. 
hnot determinable. 
NMR structural characterization 
The ability of all the here reported TBA-bs to fold into a TBA-like antiparallel quadruplex was also 
assessed by NMR spectrometry. The 1H NMR spectrum of TBA annealed in Na+ or K+ containing 
buffer is characterized by the presence of eight well resolved signals in the 11.5–12.5 ppm region, 
attributable to the exchange protected imino protons involved in the formation of two G tetrads, and 
by fifteen aromatic proton signals (6.8–8.5 ppm) attributable to H8 and H6 protons of guanine and 
thymine bases, respectively. Moreover, two peculiar upfield-shifted methyl signals of mutually H-
bonded T4 and T13 are seen at around 1.0 ppm. Finally, the alternating syn-anti-syn-anti glycosidic 
bond conformation within the two stacked G-tetrads, typical of most antiparallel quadruplexes, is 
Name aTm (K) 
bΔTm 
cTm (PBS) 
bΔTm 
dw/o±eSD 10 uM fPT ± gSE 20 uM 
TBA 50.7 0 35.1 0 0.669±0.054 49.8 ± 1.28 
TBA-Bs3  50.0  -0.7  35.4 +0.3 0.996±0.045 43.6 ± 2.15 
TBA-Bs4  51.9  +1.2  37.2 +2.1 0.700±0.093 14.1 ± 0.25 
TBA-Bs7  50.0  -0.7 34.5 -0.6 0.400±0.103 56.3 ± 0.97 
TBA-Bs8  46.4 -4.3 34.4 -0.7 0.811±0.047 25.8 ± 0.30 
TBA-Bs9 35.3  -15.4  hn.d. hn.d. 1.087±0.1059 24.8 ± 0.80 
TBA-Bs12  51.1  +0.4  35.4 +0.3 0.739±0.031 52.0 ± 1.73 
TBA-Bs13  53.3  +2.6  38.9 +3.8 0.498±0.103 12.5 ± 0.55 
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observed. As for the TBA, the quadruplex diagnostic imino signals were observed in the water 
suppressed 1H NMR spectra of the here reported TBA-bs, with the noticeable exception of TBA-
bs8 (Figure 10). Hence, the replacement of a single T residue in one of the three loops for the 
dibenzyl linker did not impede the quadruplex formation, whereas the replacement of G8, the only 
guanosine in the sequence not engaged in the two G-tetrads, did it. In particular, as we already 
observed in our previous papers [53][58], the replacement of T3 or T4 in the TBA sequence with 
acyclic nucleoside analogues induces changes in the resulting NMR profiles that are very similar to 
those induced when the replacement occurs at T12 or T13, respectively. It is interesting to note that 
the similarity observed between members of each TBA-bs3/TBA-bs12 or TBA-bs4/TBA-bs13 
couple was also observed by CD and by fibrinogen or prothrombin time assays (vide infra). 
According to the biological results, we undertook a detailed structural study of the G-quadruplexes 
formed by TBA-bs12 and TBA-bs13 by using the NMR-refined molecular mechanics approach 
[40], based on the analyses of NOE connectivities and TOCSY spectra.  
NOE connectivities in the G-quadruplex structures arise from the glycosidic bonds within the G-
tetrad, in particular between the H8/6 proton of the base and the H1′ proton of the sugar, and also 
between the H8/6 proton of the base and H1′ proton of the next base sugar, observable in a syn to 
anti conformation. Furthermore, specific NOE connectivities can elucidate the G-quaduplex folding 
topology. The cyclic NOE connectivities between the imino (H1) proton of a guanine and the H8 
proton of the next guanine are used to assess the G-tetrad alignment. Moreover, NOEs between 
imino protons of adjacent guanines can also be detected, but in many cases these cross-peaks are 
not distinctly observable. 
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Figure 10. Representative 1H NMR imino proton regions of TBA-bs incorporating the 2,2-dibenzylpropane-1,3-diol at the indicated 
position (25°C; PBS buffer, H2O/D2O 9:1). 
 
Structural investigation of TBA-bs12 
The 1H NMR spectrum of TBA-bs12 recorded at 25°C (Figure 10) was characterized by the 
presence of eight partially overlapped signals in the 11.9–12.3 ppm region attributable to the 
exchange-protected imino protons involved in the formation of Hoogsteen hydrogen bonds of two 
G-tetrads, in close analogy with previous observations on the antiparallel quadruplex formed by the 
unmodified TBA [40]. Because of the presence of the two benzene rings in the linker1at position 
12, the aromatic portion of the1H spectrum (6.8–8.5 ppm) was populated by more than the 14 
signals belonging to the protons of guanines and thymines of the G4 structure. In addition, other 
weaker signals belonging to one or more minor conformations likely including the unfolded form 
were observed in this region. With the aim of minimizing the exchange between the G-quadruplex 
and the unfolded form, we recorded the1H NMR spectrum of TBA-bs12 also at 10°C (Figure 11, 
panel A). As expected, a general simplification of the NMR spectrum was observed. In particular, at 
10°C most of the weaker signals disappeared and an improved dispersion of the signals was 
obtained. The combined analysis of 2D NOESY and TOCSY spectra (700 MHz, 10°C) allowed us 
to get the nearly complete assignment of exchangeable and non-exchangeable protons using the 
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standard procedure. The TOCSY data are not shown here, but they were used to confirm the 
assignments based on the NOESY data. The overall analysis of NOE connectivities and the 
evaluation of the Δδ between TBA-bs12 and TBA confirmed that TBA-bs12 adopts a three-
dimensional structure that is very similar to the TBA chair-like antiparallel quadruplex. In 
particular, the analysis of the intranucleotide and internucleotides H8/H6 to H1′ NOE connectivities 
(Figure 11, panel B) confirmed that four out of the eight guanosines involved in the two G-tetrads 
adopt the syn glycosidic bond conformation, as seen for TBA. The NOE connectivities between the 
methyl signal of T9 and four imino protons confirmed that T9 is stacked above theG1-G15-G10-G6 
G-tetrad (synGs are underlined) (Figure 11, panel C). Finally, the very low Δδ observed for the 
methyl signal of T4 (δ 1.07 ppm; Δδ 0.04 ppm) disclosed that the substitution of T12 with the linker 
1 did not interfere with the tertiary structure adopted by TBA-bs12, even in the close proximity of 
the substitution site, and suggested that the two benzene rings could not occupy the cleft delimited 
by the two TT loops. The latter observation is noteworthy, considering that most of the X-ray 
diffraction data of TBA-thrombin complexes have shown that the TBA recognizes the thrombin 
anion-binding exosite I (ABE I; also known as the fibrinogen exosite) by using the T3-T4 and T12-
T13 loops. To get insights about the orientation of the benzene rings of 1 with respect to the 
quadruplex scaffold, and to rationalize the effects on the antiproliferative and antithrombin 
activities shown by TBA-bs12, we performed a NMR-restrained molecular mechanics study. As we 
expected, among the 109 NMR inter proton distances used in the calculations only a few involved 
close contacts with the atoms of the linker 1, and the resulting averaged structure confirmed in full 
(Figure 12) that in the G4 structure formed by TBA-bs12, the two benzene rings are positioned 
aside from the G4 core, thus allowing its recognition by the thrombin ABE I. 
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Figure 11. NMR study of TBA-bs12 annealed in PBS/D2O 9:1 (10°C, 700 MHz). (A)1H NMR spectrum. The expansion of the imino 
proton region is shown in the inset. (B, C) Expansions of the 2D NOESY (200 ms mixing time) spectrum. The sequential H1′-H8 or 
H1′-H6 connectivities and the self-peaks involving H1′ protons have been drawn in B using dotted lines and labels, respectively. 
NOE correlations between T9 methyl protons and H8 protons of the G10-G1-G6-G15 tetrad are shown in C. 
 
 
Figure 12. 3D average structure of TBA-bs12 obtained by NMR-restrained molecular mechanics. Nucleotides are shown as sticks, 
the 2,2-dibenzylpropan-1,3-diol linker as sticks and filled rings and the phosphate backbone as a green solid ribbon. 
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Structural investigation of TBA-bs13 
The NMR structural elucidation of the G4 formed by TBA-bs13 in PBS buffer was performed as 
described above for TBA-bs12. The NMR characterization confirmed the formation of a stable 
antiparallel chair-like G4 stabilized by two G-tetrads (8 well resolved imino proton signals; Figure 
13, panel A) connected by the T3-T4, T12-X13 and T7-G8-T9 loops. Intra- and inter-nucleotide 
NOE connectivities confirmed that the methyl group of T9 is stacked above the G1-G15-G10-G6 
tetrad (Figure13, panel C) and that the two G-tetrads are made up of alternating syn and anti Gs 
(Figure 13, panel B). All together, the analysis of the 1H chemical shifts and Δδ between the NMR 
signals of TBA-bs13 and TBA indicated that the incorporation of the dibenzyl linker at position 13 
of TBA does not induce major distortions in the resulting G4 scaffold. However, differently from 
TBA-bs12, we observed a significant up-field shifting for the imino protons of G5, G6, G10, G11, 
G14 and G15, and a down-field shifting for the methyl signals of T4 and T12. These NMR evidence 
suggested that the two benzene rings of the linker were not projected aside the G4 core as found for 
TBA-bs12. Accordingly, among the 75 NOE distance restraints included in the calculations, 8 
involved NOE contacts between the atoms of the linker and those of nucleosides G11, T12 andG14. 
The resulting minimized average structure of TBA-bs13 obtained by the NMR-refined molecular 
mechanics calculations is shown in Figure 14. According to the simulated structure, the two 
benzene rings of X13 are located in the pocket delimited by the two TT loops. In particular, the ring 
coloured in red in Figure 14 is stacked exactly above the 6-membered ring of G11, whereas the blue 
ring is turned away the G2-G5-G11-G14 tetrad pointing at the T3-T4 loop. These findings are in 
agreement with the observed Δδ caused by the strong benzene rings current. 
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Figure 13. NMR study of TBA-bs13 annealed in PBS/D2O 9:1 (10°C, 700 MHz). (A) 1H NMR spectrum. The expansion of the 
imino proton region is shown in the inset. (B,C) Expansions of the 2D NOESY (200 ms mixing time) spectrum. The NOE 
connectivities between atoms of X13 and nucleotides atoms are traced and labelled in panel B. The sequential H1′-H8 or H1′-H6 
connectivities and the self-peaks involving H1′ protons have been drawn in B using dotted lines and labels, respectively. NOE 
correlations between T9 methyl protons and H8 protons of the G10-G1-G6-G15 tetrad are shown in C. 
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Figure 14. 3D average structure of TBA-bs13 obtained by NMR-restrained molecular mechanics. Nucleotides are shown as sticks, 
the 2,2-dibenzylpropan-1,3-diol linker as sticks and red and blue filled rings and the phosphate backbone as a green solid ribbon. 
 
Fibrinogen assay 
In order to assess the effect on the enzymatic activity of thrombin and to correlate the biological 
effects with the structural data, the modified ONs were tested in the fibrinogen clotting assay. The 
thrombin-induced clotting of fibrinogen was measured spectrophotometrically, following the 
increase in absorbance at 380 nm as a function of time [59]. The assay was performed using 2 mg 
per ml of fibrinogen, 1 NIH of thrombin and various concentrations of each aptamer (20, 50 and 
100 nM). The comparison of resulting data (Figure 15) evidenced marked differences among the 
modified TBA-bs in their ability to inhibit the fibrinogen clotting formation. TBA-bs12 showed an 
increased inhibitory effect relative to the unmodified sequence, at all explored concentrations. TBA, 
TBA-bs3 and TBA-bs7 prolonged the fibrinogen clotting time at almost the same extent. TBA-bs9 
and, especially, TBA-bs8 showed a significant decreased inhibitory effect relatively to TBA. Most 
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significantly, at all explored concentrations, TBA-bs4 and TBA-bs13 resulted totally unable to 
compete with fibrinogen for the binding to the enzyme. 
 
Figure 15. Fibrinogen clotting time (sec) in presence of each ON measured at three different concentrations (20, 40 and 100 nM). 
The bars of control and vehicle represent the fibrinogen clotting time values of the system in absence of any ONs and diluted with the 
buffer alone, respectively. 
 
PT assay 
To validate the results obtained from the fibrinogen clotting assay, we performed PT tests on human 
plasma (PT assay). As shown in figure 16, the PT values pointed to a trend of the anticoagulant 
activities that was almost in agreement with the antithrombin activities measured in the fibrinogen 
assay. Major difference resulted in the behaviour of TBA-bs12, which showed in fibrinogen assay, 
but not in PT test, a significant increasing in the antithrombin efficiency with respect to TBA. 
Herein, among the tested ONs, TBA-bs7 proceeded as the best anticoagulant one. The PT values 
measured in presence of TBA-bs4 or TBA-bs13 confirmed that these modified sequences were 
wholly unable to inhibit thrombin. 
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Figure 16. PT values obtained following 15 min of ON incubation with human plasma at concentration of 20 μM [ON]. Each 
measurement has been performed in triplicate and it was shown as mean ± SEM. PT values are expressed in seconds. The basal PT 
time is 13.4 ± 0.2 s. *** =P<0.001 vs. vehicle; °,°°, °°° =P<0.05, <0.01, <0.001 versus TBA. 
 
MTT test 
On the basis of literature data [43], all modified sequences and TBA were examined for their 
antiproliferative activities against He-La cervical carcinoma cell line at three different 
concentrations, 1 (Figure 17, panel A), 5 and 10 μM (Figure 17, panel B). As a result, all but TBA-
bs9 were judged to be active against this tumor cell line. Specifically, TBA-bs7 and TBA-bs13 had 
the greatest effect on the cell growth, at all tested concentrations. Notably, TBA-bs4 and TBA-bs13 
preserved the antiproliferative activity of TBA against He-La cells, but, according to fibrinogen and 
PT data, lacked in thrombin affinity. To better explore the antiproliferative effect of TBA-bs13, 
dose-response experiments at concentrations between 1.0 × 10−3and 50 μM were performed. The 
obtained clear dose-response curves indicated a 5-fold increased cell growth inhibition for TBA-
bs13 with respect to TBA (Figure 18). 
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Figure 17. Antiproliferative activity on He-La cervical carcinoma. Cells were treated with two different doses of ON, 1 (A) and 10 
(B) μM, annealed in K+ buffer (see experimental section). The bar NT (Not Treated) reports the cell viability in absence of ON. Cell 
viability was assayed seven days after addition of ON using the MTT assay. A pool of three different sets of experiments (each 
repeated in triplicate) was performed, and each value expressed as mean ± Standard Deviation. 
 
 
 
Figure 18. Concentration-dependent response in MTT assay for TBA (A) and TBA-bs13 (B). Cell viability was assayed seven days 
after addition of ON using the MTT assay. A pool of three different sets of experiments (each repeated in triplicate) was performed, 
and each value expressed as mean ± Standard Deviation. 
 
2.3. Discussion 
The findings that specific modifications of TT loops of TBA negatively interfere with its thrombin 
affinity without affecting the G-quadruplex stability [58][60], and that the antiproliferative activity 
is a general property of GT-rich ON strands [35] make ready the perspectives of modified TBAs as 
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selective antiproliferative ONs provided with the notable advantage to fold into well-defined G-
quadruplex structures. Aimed by this idea, we selected, among the commercially available acyclic 
diols, the unusual dibenzyl-linker 1 (Figure 7) as the modifying agent for the obtainment of a series 
of new TBA-based sequences (see Table 1) in which 1 (indicated as X in Table1) replaced one at 
the time the loop nucleotides of TBA. Indeed, the linker 1 provided for: (i) two hydroxyls, to make 
the required phosphoramidite building block 3; (ii) an aromatic portion, to mimic the aptitude of 
some loop residues in the TBA G-quadruplex to stack on the adjacent G-quartet [41][42]; (iii) a 
moderate bulky portion, to cause steric crash between the TBA G4 and thrombin [58]. Finally, as 
the requirements were fulfilled into symmetrical molecules, it was also ensured that the insertion of 
the linker did not give rise to diastereomeric nucleic acid sequences [60].  
CD and 1H NMR studies performed on the new synthesized TBA-bs suggested that the resulting G4 
structures strongly resembled that of the TBA (Figures 8-10). Indeed, all CD profiles showed the 
stronger positive band around 295 nm and a weak negative band around 270 nm, that are generally 
accepted as distinctive for antiparallel G4s structures [55][56]. According to the CD data, the G4 
diagnostic imino signals were observed in the 11.5–12.5 ppm region of the 1H NMR spectra of the 
new derivatives (for some examples see Figure 10), as for the TBA, with the exception of TBA-bs8. 
Furthermore, in line with previous structural data which arranged the nucleobases 3, 12 and 7 
outside the G-quadruplex core, the apparent CD melting temperatures of the G4 TBA-bs3, TBA-
bs12 and TBA-bs7 were similar to that of TBA (Figure 9 and table 2). Differently, substantial 
destabilization of the G4 structure occurred when the linker 1 occupied the position 8 or 9 of the 
TGT loop (ΔTm= -4.3 and -15.5°C, respectively, compared to that of TBA in K+ buffer; (Figure 9 
and Table2). Given that T8 and G9 stack on the G1-G15-G10-G6 quartet, thus stabilizing the TBA 
G-quadruplex core, the obtained Tm values suggested that neither of the two benzene rings of the 
linker 1 efficiently mimic the role of the replaced nucleobase in the G4 structure formed by TBA-
bs8 and TBA-bs9. 
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 Interestingly, stable antiparallel G4s were obtained from the folding of TBA-bs4 and TBA-bs13 
(Tm= 51.9 and 53.3°C, respectively, in K
+ buffer; 37.2 and 38.9°C in PBS; Table 2), thus suggesting 
that the aromatic moieties at position 4 or 13 could provide for the stacking interactions with the 
nucleobase on the adjacent quartet (G2-G5-G11-G14). 
The results from PT and fibrinogen assays (Figures 15-16) allowed us to assess the involvement of 
the linker 1 in the formation of TBA-thrombin complex, while those from the MTT assay (Figures 
17-18) the influence of 1 on the TBA cytotoxicity. By modifying the TGT loop, it resulted that 
TBA-bs8 and TBA-bs9, that folded into the least stable G4 structures, still affected, although with 
reduced efficiency, the coagulation time measured in both the fibrinogen and PT assays (Figures 
15-16) and showed the lowest antiproliferative effects in the MTT test on He-la carcinoma cell line 
(Figures 17-18). On the other hand, both the anticoagulant activity and the cytotoxic effect of TBA-
bs7 resulted increased. These results could reflect a tighter correlation between the structural 
stability of G4s and the antiproliferative activity [26][35], than that observed with the antithrombin 
efficiency [60][58]. Indeed, among these three ONs, the best-structured TBA variant (TBA-bs7) 
was also the strongest growth-inhibitor agent and viceversa (TBA-bs9). However, none of these 
ONs showed a selective action with respect to the two functional effects. Consequently, their G4 
structures were not further investigated. The most relevant outcomes emerged from TBA variants 
modified at one residue of the TT loops. In fact, although the corresponding G4s had Tm values very 
similar to each other (ΔT < 3.3°C; Table 2), their biological properties were significantly different. 
In the MTT assay (Figures 17-18), TBA-bs4 and TBA-bs13, which resulted totally unable to act as 
anticoagulant agents (Figures 15-16; Table2), showed significant cytotoxic effects on He-La cells, 
and TBA-bs13 was a better inhibitor of cell growth than TBA. Contrarily, TBA-bs3 and TBA-bs12 
afforded to a good correlation between structure stability, antithrombin and antiproliferative 
activities (Figures 15-18, Table 2).  
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The biological properties of the last two sequences were almost comparable to that of TBA. 
Nevertheless, it was also observed that the increased antithrombin activity of TBA-bs12 with 
respect to TBA, measured in fibrinogen assay (Figure 15), was not observed in the PT test (Figure 
16, Table 2). Such incoherence between the fibrinogen and PT data was previously observed by us 
and others for other TBA variants, and supports the hypothesis that the clotting inhibitory activity 
of some modified TBAs could not wholly depend on the ability of the aptamers to compete with 
fibrinogen for thrombin ABE I. In fact, the presence in the plasma medium of other thrombin 
effectors and/or precursors, and the thrombin allostery, which regulates the complex thrombin 
action during homeostasis, could also play an important role in determining the anticoagulant effect 
of such type of TBA derivatives. However, the overall results evidenced that, despite the TBA G-
quadruplex well sustained the replacement of one T with the linker 1at any position of the TT loops, 
the TBA-thrombin complex did not tolerate such modification at T4 or T13. Furthermore, the 
results were consistent with the TBA tertiary structure, which leads residuesT3 and T12, as well as 
T4 and T13, to occupy equivalent positions with respect to the G quartets. Nevertheless, TBA-bs12 
and TBA-bs13 are slightly more potent inhibitors of cell growth than TBA-bs3 and TBA-bs4, 
respectively (Figures 17-18). At the best of our knowledge, this is the first evidence that loop 
structure is a further parameter capable to affect the antiproliferative efficiency of the TBA G-
quadruplex in addition to G4 stability. 
To better understand the requirements to discriminate between the antiproliferative and 
antithrombin effects, we undertook an extensive 2D NMR study of the G4s formed by TBA-bs12 
and TBA-bs13 in PBS buffer. The inspection of the NMR-restrained molecular mechanics average 
G4 structure of TBA-bs12 (Figures 11-12) confirmed that the two benzene rings of1are projected 
outside the G4 core. In contrast, in the corresponding average structure obtained for TBA-bs13, the 
benzene ring coloured in red in figure 14 stacked exactly above the 6-membered ring of G11, 
whereas the blue ring turned away the G2-G5-G11-G14 tetrad pointing at the T3-T4 loop. These 
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findings agree in full with the anticoagulant activities showed by TBA-bs12 and TBA-bs13. In fact, 
a lot of structure-activity relationships and the analysis of several X-ray TBA-Thrombin complexes 
[42], showed that the TBA G-quadruplex interacts with thrombin mainly through the TT loops 
region. Particularly, essential polar interactions between the nucleobases T4, T13 and G5 of the 
tertiary structure and the side chains of Arg 77, Arg 75 and Tyr 76 located in the ABE I of the 
thrombin take place, whereas T3 and T12 are essentially involved into hydrophobic contacts. Given 
that the dibenzyl linker was positioned outside the TT loops, the modification at T12 did not 
provoke substantial alteration in the TT loops region of the resulting G4, and almost all the above 
mentioned contacts between TBA and thrombin could occur. As opposite to this, the G-quadruplex 
bioactive conformation could be significantly affected by the replacement of T13 with the dibenzyl 
linker1, seeing that the two benzene rings occupied the region between the TT loops. Consequently, 
despite the overall topology of the G4 formed by TBA-bs13 strongly resembled that of TBA, the 
formation of a stable TBA-thrombin complex was completely prevented. 
Finally, the cytotoxic effect of TBA-bs13 on the He-La cell line was studied in comparison with 
that of TBA by means of MTT dose response experiments at concentrations in the range of 0.001–
50 μM (Figures 17-18). Inhibition of cell growth by TBA-bs13 started at 0.1 μM and reached the 
maximum effect at 10 μM, whereas TBA produced the same effects at concentration in the range of 
1–50 μM. Consequently, TBA-bs13 was significantly more potent than TBA in the inhibition of 
He-La cell line growth. 
Interestingly, it has been ascertained that some G4s bind NOA1 [49], a large GTP binding protein 
involved in important mitochondrial functions such as the synthesis of specific proteins, cellular 
respiration and apoptosis [48][61]. In particular, both parallel and antiparallel DNA G4s are able to 
bind NOA1, but only the antiparallel ones also cause an increasing of about 4–5 folds of the NOA1 
GTP-ase activity [49]. The GTP dependent allosteric regulation has also been established for other 
GTP binding proteins involved in cancer development, survival and resistance [61][62]. In light of 
the ability of TBA (antiparallel G-quadruplex) to accumulate into mitochondria [45], it will be of 
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interest to verify the existence of such connection between the antiproliferative activities of new 
TBAs on He-La cells and the NOA1 functionality into mitochondria and/or in other cellular 
districts. 
 
2.4. Conclusion 
In conclusion, we showed that artful modifications in the TBA could provide cytotoxic GROs 
which are able to fold into the well-known TBA G-quadruplex topology but avoiding the TBA 
anticoagulant action. In particular, the replacement of the residue 4 or 13 with the dibenzyl 
linker1afforded two TBA variants, specifically TBA-bs4 and TBA-bs13, which resulted unable to 
inhibit thrombin but showed significant antiproliferative activity against the He-La cell line. TBA-
bs13 showed a 5-fold increased cell growth inhibition relative to the TBA as determined by the 
MTT dose response assay. The data concerning the other modified TBAs showed that none of them 
had a selective action relative to either the biological properties of TBA. It is noteworthy that TBA-
bs9, which folded into the least stable G4, showed the lowest antiproliferative activity at all the 
explored concentrations. A good correlation between the structure stability and the antiproliferative 
action on He-La cells was also observed for the other two TBA-bs modified at one residue of the 
TGT loop, TBA-bs7 and TBA-bs8. Among the here reported new analogues, TBA-bs7 showed to 
be the best inhibitor of He-La cell line growth. Nevertheless, the presented data also demonstrated 
that more complex phenomena than the G-quadruplex stability control the difference in the 
antiproliferative effects of the TBA-bs obtained by replacing one of the residues in the TT loops of 
the TBA with the dibenzyl linker 1. 
Although further deepened studies on these new TBA variants are certainly necessary, we herein 
described a potential route to obtain helpful G-quadruplex tools for the understanding of the 
molecular factors that contribute to the cytotoxicity of quadruplex-forming GROs. 
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2.5. Experimental section 
Chemicals and anhydrous solvents were purchased from Fluka-Sigma-Aldrich. TLCs were run on 
Merck silica gel 60 F254 plates. Silica gel chromatography was performed using Merck silica gel 
60 (0.063–0.200 mm). The API 2000 (Applied Biosystems) mass spectrometer was used to perform 
the analyses of the intermediates and the monomer. NMR data were collected on Varian Mercury 
Plus400 and UNITY INOVA 500 MHz spectrometers equipped with a broadband inverse probe with 
z-field gradient, and on a VarianUNITY INOVA 700 MHz spectrometer equipped with a triple 
resonance cryoprobe. The data were processed using the Varian VNMR and the iNMR 
(http://www.inmr.net) software packages. Reagents and phosphoramidites for DNA syntheses were 
purchased from Glenn Research. ON syntheses were performed on a PerSeptive Biosystem 
Expedite DNA synthesizer. HPLC purifications and analyses were carried out using a JASCO PU-
2089 Plus HPLC pump equipped with a JASCO BS-997–01 UV detector. CD experiments were 
performed on a JASCO 715 spectropolarimeter equipped with a PTC-348 temperature controller. 
The fibrinogen assay was performed using a JASCO 530 UV spectrophotometer equipped with the 
PTC-348 temperature controller. 
Synthesis of monomer phosphoramidite building block 3 
Compound 2. 2,2-dibenzylpropane-1,3-diol (1.0 g, 4.1 mmol), 4,4′-dimethoxytrityl chloride (696.0 
mg, 2.0 mmol) and 4-dimethylaminopyridine (25 mg, 0.21 mmol) were dissolved in dry pyridine 
(20 ml) and dry CH3CN (10 ml). The resulting solution was stirred at room temperature (r.t.) under 
argon for 1.5 h. Dry methanol (200 μl) was then added to quench the reaction. After 30 min under 
stirring, the solution was concentrated under reduced pressure and the residue purified by column 
chromatography on silica gel (eluted with 90:10:0.1 DCM/MeOH/Et3N) to give 
monodimethoxytritylated 2 as a clear white solid (40% yield from 1; Rf 0.7 in DCM/MeOH 90:10 
v/v). 
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1H NMR (400 MHz, CDCl3) δ ppm 7.26–7.00 (19H); 6.90 (4H); 3.78 (s, 6H); 3.72 (s, 2H); 3.45 (s, 
2H); 2.89 (s, 2H); 2.47 (s, 2H). 
13C NMR (100 MHz, CDCl3) δ ppm 156.1; 145.5; 139.9; 137.2; 130.0; 129.8; 129.2; 128.2; 127.4; 
127.0; 126.6; 126.4; 124.2; 113.9; 89.1; 69.9; 60.7; 55.8; 40.5; 39.4. 
ESI mass (positive mode) calculated 558.28; found 559.3 [M + H]+, 581.3 [M + Na]+. 
Compound 3. 2 (425 mg, 0.76 mmol) was dried in vacuo overnight before being dissolved in 
anhydrous DCM (8 ml) and diisopropylethylamine (530 μl, 3.0 mmol) under argon. 268 μl of β-
cyanoethyl diisopropylchlorophosphoramidite was then added (1.2 mmol). After 40 min, the 
reaction was diluted with ethyl acetate (15 ml), and finally washed with 10% sodium carbonate 
solution (15 ml) and brine (15 ml). The organic layer was dried on magnesium sulphate and 
concentrated in vacuo. The residue was purified by silica gel chromatography eluted with DCM, 
ethyl acetate and triethylamine (80:10:10). The fractions containing the product were collected and 
concentrated under vacuum, yielding 3 as white foam (85% yield; Rf 0.65 in CHCl3/MeOH/Et3N 
97:3:0.05 v/v/v). 
1H NMR (400 MHz, CDCl3) δ 7.90–6.85 (23H); 3.90 (2H); 3.76 (6H); 3.65 (2H); 3.60 (2H); 3.45 
(2H); 3.39−3.02 (2H); 2.60−2.45 (4H); 1.09 (6H); 1.04 (6H). 
13C NMR (175 MHz, DMSO-d6) δ 158.6; 151.6; 147.3; 139.4; 135.1; 130.3; 129.1; 127.8; 127.7; 
127.1; 126.4; 126.1; 124.2; 113.1, 90.5; 71.2; 64.4; 60.4; 55.2; 47.3; 33.6; 29.7; 27.6; 20.9; 19.3; 
17.3. 
ESI mass (positive mode) calculated 758.3; found 759.9 [M + H]+, 781.9 [M + Na]+. 
Synthesis of oligomers 
TBA and TBA-bs were synthesized using standard solid phase DNA chemistry on a controlled pore 
glass (CPG) support following the β-cyanoethyl phosphoramidite method [54]. The coupling time 
for the modified monomer was prolonged from 2 min to 10 min. The oligomers were detached from 
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the solid support and deprotected by treatment with an aqueous ammonia solution (33%) at 55°C 
overnight. The combined filtrates and washings were concentrated in vacuo, dissolved in H2O, and 
purified by HPLC using an anionic exchange column eluted with a linear gradient (from 0% to 
100% B in 30 min) of phosphate buffer at pH 7.0 (A: 20 mM NaH2PO4 aqueous solution containing 
20% CH3CN; B: 1.0 M NaCl, 20 mM NaH2PO4aqueous solution containing 20% CH3CN, elution 
time 18.9 min). The oligomers were successively desalted by molecular exclusion chromatography 
on Biogel P-2 Fine. The purity (95%) was checked on HPLC using an analytical reverse phase 
column (Phenomenex, Clarity Oligo-RP, 3 μm, 2 × 10 mm) eluted with a gradient of CH3CN in 
triethylamine acetate (pH = 7.4, CH3CN from 0% to 100% in 40 min). The concentrations of the 
samples used in CD and UV experiments were determined by measuring the absorbance at 260 nm 
at 80°C and using the open access program available 
at http://basic.northwestern.edu/biotools/OligoCalc.html[64]. 
CD experiments 
To perform the CD experiments on modified TBA sequences, each ON was dissolved in K+buffer 
(90 mM KCl, 10 mM KH2PO4, pH 7.4) or PBS (Phosphate Buffered Saline) at the final ON 
concentration of 2.0 × 10−5M and submitted to the annealing procedure (heating at 90°C for 5 min 
and slowly cooling at r.t.). Before each experiment the samples were equilibrated at 10°C for 30 
min. CD spectra were recorded from 200 nm to 400 nm at 100 nm min−1scanning rate, 16 s 
response, 2.0 nm bandwidth, cell length 0.1 cm, vol. 400 μl. Each CD profile was obtained by 
taking the average of three scans. CD melting curves were obtained by monitoring the variation of 
absorbance at 295 nm from 10°C to 90°C, cell length 1 cm, vol 1400 μl, temperature scan speeds of 
0.1 and 0.5°C min−1. 
Furthermore, the CD melting experiments in K+ buffer were also performed at ON concentrations of 
1.0 × 10−4and 8.3 × 10−6M. These samples were obtained by diluting a 1.0 × 10−3M sample, 
properly annealed in K+ buffer. The samples at 1.0 × 10−4M were subjected to the melting-annealing 
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experiments (cell length 0.1 cm, vol 400 μl), whereas those at 8.3 × 10−6M to the annealing-melting 
experiments (cell length 0.5 cm, vol 1200 μl). The temperature scan speed was fixed at 0.2°C min−1. 
Fibrinogen clotting assay 
The fibrinogen clotting times were measured spectrophotometrically following the procedure 
previously described [59] ONs were incubated for 1 min at 37°C in 1.0 ml of PBS containing 2.0 
mg/ml of fibrinogen (fibrinogen from human plasma, F 3879, Sigma-Aldrich) in a PMMA cuvette 
(vol 1.5 ml, cell length 1 cm, Brand). 100 μl of human thrombin (10 NIH per ml; Sigma-Aldrich, 
T8885, human thrombin suitable for the thrombin time test) was then added to the solution 
containing the fibrinogen and the ON. For each ON, three sets of experiments at concentration of 
20, 50, 100 nM were performed. The time required for fibrin polymerization was determined from 
the UV scattering curve, registered, as a function of time (wavelength fixed at 380 nm), in triplicate 
for each ON concentration. The clotting time value reported as mean ± SE was derived as the 
maximum of the second derivative of each scattering curve. The basal clotting time (25.6 ± 1.5 s) 
was referred to the clotting time value determined in absence of any ONs. 
NMR experiments 
NMR samples were prepared in PBS/D2O (90:10, v/v) at a single strand concentration of about 5 
mM. One-dimensional NMR spectra were acquired as 16384 data points with a recycle delay of 1.0 
s at 25°C. Data sets were zero filled to 32768 points prior to Fourier transformation and apodized 
with a shifted sine bell squared window function. Two-dimensional NMR spectra of TBA-bs12 and 
TBA-bs13 were acquired at 10°C using a recycle delay of 1.2 s. NOESY spectra were acquired with 
mixing times of 100, 200 and 300 ms. TOCSY spectra were recorded with the standard MLEV-17 
spin-lock sequence and a mixing time of 80 ms. Water suppression was achieved by including a 
double pulsed-field gradient spin-echo (DPFGSE) module in the pulse sequence prior to 
acquisition. In all 2D experiments, the time domain data consisted of 2048 complex points in t2 and 
400 fids in t1 dimension. The sequence-specific resonance assignment of all proton signals of TBA-
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bs12 and TBA-bs13 was obtained using NOESY and TOCSY spectra following the standard 
procedure. 
Molecular modelling 
The initial structure of TBA-bs12 and TBA-bs13 was built using as the starting point the 
coordinates of the NMR solution structure of TBA quadruplex (PDB id. 148D). The nucleoside T12 
or T13, respectively, was replaced with the linker 1 (Figure7) by using the builder module of the 
Insight II (2005) software package (Accelrys). The obtained molecules were parameterized 
according the AMBER force field and the atom of the linker 1 were selectively minimized using the 
steepest descent and conjugate gradient minimization methods until convergence to a RMS gradient 
of 0.001 Kcal mol−1 was reached. The structures were then neutralized by adding 14 sodium 
counterions and solvated in a square TIP3P water box (38 × 38 × 38 Å). Water molecules were 
minimized (RMS ≤ 0.1 Kcal mol−1) and the systems were subjected to NMR-restrained energy 
minimization (steepest descent and conjugate gradient methods until convergence to a RMS 
gradient of 0.001 Kcal mol−1) as described below. The systems were first minimized using the 
following restraints: 109 or 75 quadratic interproton distances (fixed-length; 30 Kcal mol−1force 
constant) for TBA-bs12 or TBA-bs13, respectively; 32 flat-bottomed hydrogen bond constraints (16 
hydrogen/acceptor 1.7–2.0 Å and 16 donor/acceptor 2.7–3.0 Å; 100 Kcal mol−1); 5 glycosidic 
torsion angles constrained to a range of –160°/–70° (flat bottomed; 200 Kcal mol−1) as required 
forantiGs; 4 glycosidic torsion angles constrained to a range of 10°/100° (flat bottomed; 200 Kcal 
mol−1) as required forsynGs. Next, the distance restraints were removed and the systems were 
subjected to a second minimization. Finally, all restraints were removed and a final energy 
minimization was performed. All calculations were repeated 10 times on each system until 
convergence at the RMS gradient ≤0.001 Kcal mol−1was reached. For each system the average 
minimized structure was then obtained by using the analysis module of the Insight II 2005 software 
package. The average RMSD value was 0.988 Å for TBA-bs12 and 0.983 Å for TBA-bs13. 
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Prothrombin (PT) Time 
PT time was measured by using a Koagulab MJ Coagulation System with a specific kit 
RecombiPlas Tin HemosIL (Instrumentation Laboratories, Lexington, MA, USA). The procedure 
was performed according to the manufacturer's instructions. In our experimental protocol a time 
course (up to 15 min) of each ON or vehicle with 100 μl of plasma at 37°C was performed. In 
details, 2.0 μl of the corresponding ON solution (1.0×10−3M in PBS) or vehicle (PBS) was added in 
the apposite microtube, to achieve the final concentration of 20 μM. Similarly, to reach the final 
concentration of 2 μM, 2.0 μl of 1.0 × 10−4 M ON solution was added to 100 μl of plasma at 37°C. 
Next, 200 μl of the kit solution containing Recombiplastin was added with consequent activation of 
the extrinsic pathway. The PT measurement was produced in triplicate, and the average and its 
standard error values were calculated. The basal clotting time was determined by measuring the 
clotting time in the absence of any ON (13.4 ± 0.2 s). The incubation with PBS did not modify the 
PT measurement. 
MTT test 
He-La cervical carcinoma cells were seeded in a 96-well plate at a density of 250 cells/well in 
Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Briefly, 24 h after 
being cultured, cells were treated with the different ONs for 7 days and afterward 20 μl of MTT 
solution (5 mg/ml, Sigma-Aldrich) was added into each well and incubated for 4 h. The growth 
medium was then removed and replaced with 4 mM HCl, 0.1% Nondet P-40 (NP40) in isopropanol 
(150 μl/well) in order to dissolve the blue-purple crystals of formazan. The absorbance was then 
measured using a Microplate Reader at 595 nm. Cell viability of triplicate cultures was assessed and 
graphed together with the corresponding standard deviation. 
This work was published on: Nucleic Acids Res. 2015 Sep 18; 43(16): 7702–7716. 
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3. DNA aptamers as potential anti-HIV agents 
3.1. Structural Studies and biological evaluation of T30695 variants modified with single 
chiral glycerol-T reveal the importance of LEDGF/p75 for the aptamer Anti-HIV-
Integrase activities 
 
Currently, HIV-1 infection treatment guidelines adopted in USA and EU provide for the 
simultaneous administration of 3 antiretroviral drugs (HAART “Highly Active Anti-Retroviral 
Therapy”) in severely compromised patients [65][66]. Coupling at least two different mechanisms 
of action, (i.e. nucleoside reverse transcriptase inhibitors (NRTIs) plus either a non-nucleoside 
reverse transcriptase inhibitor (NNRTI) or a protease inhibitor) this therapeutic approach interferes 
at different stages of the viral life cycle and efficiently suppresses the viral replication, both 
reducing the risks of disease-related morbidities and increasing the life expectancy. Nevertheless, 
significant side effects associated with poor drug tolerability compromises the long-term treatments 
with HAART. Indeed, recent data show that an increasing number of patients stop HAART mainly 
for the persistence of severe side effects. These behaviors in turn trigger the evolution of drug 
resistant viral phenotypes which pose the major clinical problem.  
The other issues pointed out by non-profit word-wide organizations [67] include the increased HIV 
spread among young people. Contrarily to the common perception, these problems are not confined 
to the African populations but are present worldwide. To defeat AIDS/HIV risks and infectious, at 
least two crucial intervention policies are challenged. The first one has to guarantee an efficient 
word-wide prevention campaign turned to young people. The latter has to support researches on 
HIV resistance and survival mechanisms including alternative anti-HIV drug discovery.  
Several aptamers have been developed against infective agents with special attention on HIV [68] 
[69]. Indeed, GQ forming DNA aptamers are selected against the envelope glycoprotein gp120, or 
the HIV-Integrase, or the HIV reverse transcriptase, etc. Thus, each of these aptamers should inhibit 
the viral life cycle (Figure 19) at different stage [68]. 
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Figure 19. Schematic representation of the viral life cycle [from Nat.Rev.Microbiol., vol. 10, no. 4, pp. 279–290, 2009]. The 
glycoprotein gp120, exposed on the surface of the HIV envelope (Env), recognizes and binds the receptor CD4 and co-receptor CC-
chemokine receptor 5 (CCR5) (step 1), leading to the fusion and to the entrance of the viral particles into the cell (step 2). The 
uncoating of the viral capsid (step 3) leads to the release of the viral genomic nucleic acid and to the reverse transcription (step 4), 
providing the pre-integration complex (PIC). After the entrance into the cell nucleus (step 5), PIC-associated integrase turns into the 
integrated provirus, aided by the host chromatin-binding protein lens epithelium-derived growth factor (LEDGF) (step 6). Proviral 
transcription (step 7), mediated by host RNA polymerase II (RNA Pol II), produces different viral mRNAs, which require energy-
dependent export to leave the nucleus via host protein CRM1 (Chromosomal Region Maintenance 1 protein, also known as Export in 
1) (step 8). mRNAs are used as templates for protein production (step 9), and genome-length RNA is incorporated into viral particles 
with protein components (step 10). Viral-particle budding (step 11) and release (step 12) from the cell is mediated by ESCRT 
(endosomal sorting complex required for transport) complexes and ALIX (ALG-2-interacting protein X) and is accompanied or soon 
followed by protease-mediated maturation (step 13) to create an infectious viral particle.  
 
As an example, the 17-base oligonucleotide (ON) named T30177 (5’-GGTGTGGGTGGGTGGGT-
3’, Figure 20a) inhibits HIV-1 integrase at nanomolar concentrations [70]. A sub-sequent 
revaluation of pharmacological properties of T30177 also showed that it binds to the viral envelop 
protein gp120, impairing the host-viral CD4-gp120 interaction [71]. Phase I clinical trials of 
Zintevir, an analog of T30177 containing phosphorotioate groups at specific positions, 
demonstrated its potent antiviral activity on humans; however, excluding some specie-specific 
toxicity at high drug dose, Phase II was discontinued. 
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Additional studies showed that the T30177 variant, named T30695 (5’-GGGTGGGTGGGTGGGT-
3’) in which the depletion of the T residue at position 3 produces a continuous 5’-end G3 tract, had 
increased antiretroviral activity with respect to the parent variant. Similarly, to T30177, T30695 
also binds to HIV-Integrase, inhibiting the enzymatic activity at 3’-end processing stage. Structure-
activity studies established a tight correlation between the GQ stabilities and the integrase inhibitory 
efficiencies of these two aptamers [72][73].Recently, Phan and coworkers have solved both the 
T30177 and T30695 GQ structures in buffered solution using NMR techniques (Figure 20a-
b)[74][75]. Elegantly overcoming the difficulties related to the symmetry of these GQ typologies, 
they have shown that parallel-stranded monomers of both T30177 and T30695-GQs stack at 5'-ends 
to form very stable GQ dimers (Figure 20a-b). 
However, dissecting the exact binding mode of T30695 to IN has remained elusive due to the 
biological complexity of the viral integration machinery, which includes the ability of IN to adopt 
various multimeric forms [76][77]. Sgobba et al. built a molecular model for (HIV-IN)4-93del 
complex [78] and suggested that T30695 could interact with HIV-1 IN in a similar manner. Indeed, 
93-del is a 16-mer ON (5’-GGGGTGGGAGGAGGGT-3’), firstly reported as an inhibitor of the 
RNAse H activity, that also exerts HIV-IN inhibition at nanomolar concentration [79]. It adopts a 
dimeric GQ structure, (Figure 20c) named interlocked, comprising two parallel-stranded GQ 
subunits, which are singularly engaged with each other through the G-base at the 5’-end (Figure 
20c) [80]. In the proposed (HIV-IN)4-aptamer complex models, T30695 or 93-del GQ occupy the 
positively charged cavity of HIV-1 IN tetramer. The aptamers bind to an IN tetramer, principally, 
through their phosphate groups, interacting with basic residues and amide backbones mainly 
localized at the base of the IN tetramer cavity. Further interactions could involve T bases in the 
loops of the GQs. Because of their six and two single T loops, T30695 and 93-del GQs could 
exhibit different binding energy interactions with HIV-1 IN tetramer, with more favorable free 
energy variation values obtained for the formation of (HIV-IN)4-T30695 complex [78]. 
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Figure 20. Schematic representation of dimeric G-quadruplexes of T30177 (a), T30695 (b), and 93-del (c). Continuous and dashed 
lines represent phosphate backbones connecting G residues and T loops (a and b) or G residues and T or A loops (c). 
 
Despite the two models for the HIV-1 IN-aptamer complexes appeared to be comparable, 
disintegration assays revealed that 93-del inhibited C- or N-terminally truncated enzyme at the same 
extent, [79] whereas, T30695 required N-terminal domain (NTD) of the enzyme to exert its 
integrase inhibitory activity [81]. 
These observations suggest that the two aptamers differently interact with the NTD, and the 
proposed molecular model of the (HIV-1 IN)4/T30695 complex needs to be further refined.  
 
3.2. Results and discussion 
To gain additional information on the mechanism of action of T30695 and its analogues we have 
extended structure−activity relationships (SARs) studies through the development of new 
derivatives of T30695. In particular, for the reasons given above, modifications at the loop residues 
were targeted as they could influence the binding ability of T30695 GQ to HIV-1. We synthesized 
T30695 variants, in which the R or S chiral acyclic nucleoside 1, named glycerol T, (Figure 21) 
singly replaced the thymine residues at the T30695 loops. Because of its impact on both phosphate 
a b c 
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backbone and/or spatial orientation of nucleobase, R and S glycerol T are good candidates as T 
analogues to modify T30695 GQ loops. The rational basis of this approach lays in a previous study 
[58] which demonstrated that, in the folded thrombin binding aptamer G-quadruplex (TBA-GQ), 
the two phosphate backbones adjacent to the R and S modified monomers can reach the same 
conformation, while the corresponding T nucleobase projected at opposite side. As a consequence 
of the nucleobase orientation, the two TBA-GQs containing either the R or the S glycerol nucleoside 
at specific positions also showed opposite trends in their antithrombin activity [58]. These results 
prompted us to examine the influence of T loop replacement with either R or S glycerol T on 
thermal stability and on biological activity of T30695-GQ. Circular dichroism (CD) melting, 
electrophoretic mobility shift assay (EMSA), and high resolution mass spectrometry (HRMS) 
experiments provided information about the thermal stability and the stoichiometry of T30695-GQ 
variants, whereas CD and 1H NMR studies were performed to evaluate the effect of the 
modification on T30695-GQ typology. Furthermore, LEDGF/ p75 dependent and independent 
integration assay were carried out to evaluate the impact of T loop modification on T30695-GQ 
biological activities.  
 
 
Figure 21. Glycerol T instead of T residue reduces by one bond the phosphate backbone (colored in red). 
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CD and CD-based melting experiments reveal that the R or S chirality of one glycerol T loop 
differently affects the stability of T30695-GQ, largely in presence of Na+  
CD studies on folded GQs of T30695 and its analogues were performed using three different buffer 
solutions: K buffer (10 mM potassium phosphate buffer, 10 mM KCl, pH=7,4), PBS (Sigma-
Aldrich), and Na buffer (10 mM sodium phosphate buffer, 60 mM NaCl, pH=7,4). As shown in 
figure 22, T30695 and its derivatives showed similar CD profiles in all the examined salt 
conditions. Particularly, three positive CD bands at about 209, 262 and 303 nm and one negative 
CD band at 242 nm were present [55][56][73][74][82]. The CD band at 262 nm always had the 
highest absolute intensity. These data suggested that the G4 structures formed by the new modified 
sequences strongly resembled that formed by T30695 [74]. 
 
Panel A 
 
Panel B 
 
Figure 22.  Panel A and B. CD spectra of T30695 and its analogues in K (10 mM potassium phosphate buffer, 10 mM KCl, pH=7,4) 
and Na Buffer (10 mM phosphate buffer, 60 mM NaCl, pH 7,4), respectively. CD profiles of variants containing the R or S acyclic T 
residue are shown in the corresponding R or S picture T30695 (black), T30695-r4and T30695-s4, (blue), T30695-r8and T30695-s8 
(red), T30695-r12and T30695-s12 (green). Each aptamer is used at final concentration of 20 μM. Cuvette o.l. 0.1 cm. 
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Figure 23. CD melting experiments in K buffer. In all panels, the black line refers to the CD melting profile of T30695, 
whereas continous or dotted blue, red and green lines are referred to modified T30695 containing the R or S acyclic T 
residue at position 4 (Panel A) or 8 (Panel B) or 12(Panel C). Cuvette o.l. 0.5 cm. 
 
 
 
 
 
 
 
Figure 24.CD heating (blue) and cooling (green) profiles of T30695 and T30695 variants. Fixed wavelength 263 nm, [ON] 
of2.0×10-5 M. Cell length 0.5 cm. Temperature scan speed 0.2 °C/min. K buffer (10 mM KCl, 10 mM potassium phosphate buffer, 
pH 7.4). 
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Figure 25. CD melting experiments in Na buffer. In all panels, the black line is referred to the CD melting profile of 
T30695, whereas continous or dotted blue, red and green lines are referred to modified T30695 containing the R or S 
acyclic T residue at position 4 (Panel A) or 8 (Panel B) or 12(Panel C). Cuvette o.l. 0.5 cm. 
 
 
 
 
Figure 26.CD heating (blue) and cooling (green) profiles of T30695 and T30695 variants. Fixed wavelength 263 nm.[ON] of 2.0×10-
5
 M. Cell length 0.5 cm. Temperature scan speed 0.2 °C/min. Na buffer (10 mM sodium phosphate buffer, 60 mM NaCl, pH=7,4). 
 
On the basis of previously reported NMR structural data [74][75][83]. T30695 folds into a dimeric 
G4 structure, formed by 5'-5' end-to-end stacking of two monomolecular G4s, each of them 
containing four parallel strands and three reversed T loops. Assuming that the new aptamers are 
able to fold into similar G4s, the acyclic T residue must arrange one T loop of each monomeric G4. 
In order to evaluate the effects of the T loop modification on GQs stabilities, we performed CD-
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based heating and heating/cooling experiments using the three above mentioned buffered conditions 
(Figures 23-26, table 3). In presence of Na+ or K+ ions almost all the acquired CD heating/cooling 
curves showed two inflection points, suggesting that two different events, dimeric GQs→GQs 
monomers→single strands, occurred in the solutions [11][84]. In presence of K+ ions, the CD 
heating-cooling curves showed thermal hysteresis between 10 and 55-60 °C, whereas they were 
almost the same in the range of 55-90 °C (Figure 24). These behaviors suggested that, in most of 
examined cases, the used rate of heating or cooling (0.2°C min-1) was faster than the rate of the 
interconversion 5'-5' end-to-end stacked dimeric GQs→GQs monomers. However, the 
monomolecular folding/unfolding processes should occur at equilibrium (Figure 24). Accordingly, 
T1/2 for the event dimers→ monomers (i.e. the temperature at which 50% of the initial stacked GQ-
dimers still existed in the solution) and Tm (i.e. the melting temperature of GQ-monomers), were 
achieved from each CD heating curve (Figures 23-24 and table 3). 
In view of the ascertained ability of K+ ions to stabilize GQ structures better than NH4
+ or Na+ ions, 
in K+ containing buffer [9][85], all the CD heating/cooling curves (Figures 23-24) showed the 
occurrence of the two unfolding events at higher temperatures than in all the other explored 
conditions. However, in presence of the K+ ions the replacement of a T residue at position 4, 8 or 12 
with either R or S acyclic T always negatively affected the thermal stability of T30695 G4 structure 
(Table 3). 
The trend in the GQ thermal stabilities was almost unchanged also using PBS buffer (in addition to 
Na+, this buffer also contains small quantities of K+) (Table 3) ,or ammonium acetate buffer 
(Figures 32-33), with all Tm values being lower than those observed in the K
+ containing buffer.  
Finally, in the Na+ containing buffer T30695-r4, T30695-r8 and T30695-r12, GQs had similar 
thermal stability than that of T30695 (Figures 25-26 and table 3). CD heating/cooling curves 
showed a less pronounced first inflection point than in the presence of K+ ions (Figure 24). Most 
importantly, the R or S chirality of the acyclic T significantly affected the monomolecular T30695-
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GQ stability (Table 3 and Figure 26). Indeed, Tm of T30695-r4, T30695-r8 and of T30695-r12 GQs 
were, respectively, of 16, 11 and 10 °C higher than that of T30695-s4, T30695-s8 andT30695-s12.  
 
ON K buffer PBS Na buffer 
T1/2 Tm aΔTm  T1/2 Tm aΔTm T1/2 Tm aΔTm R,S bΔTm 
T30695 56 86 ― 55 78 ― N.D. 64 ― ― 
T30695-r4 54 80 -6 50 72 -6 40 67 +3 16 
 T30695-s4 49 79 -7 ND 70 -8 22 51 -13 
T30695-r8 55 77 -9 50 72 -6 N.D. 65 +1 11 
T30695-s8 55 81 -5 50. 70 -8 N.D. 54 -10 
T30695-r12 50 81 -5 50. 72 -6 N.D. 67 +3 10 
T30695-s12 50 80 -6 50. 72 -6 N.D. 57 -7 
 
Table 3. T1/2 and Tm of T30695-GQ and of its variants annealed in different buffer solutions. aΔTm is the 
difference between the Tm of each variant and that of T30695 in each reported buffer. bΔTm is the 
differences between the Tm of the two variants containing the acyclic T as R and S stereomer in Na+ 
containing buffer.  
 
 
Despite the chirality of the glycerol T in one T30695 loop could affect the GQ thermal stabilities in 
different manners and could imply the involvement of different phenomena, (i.e changes in loop 
hydrations and length could result in increasing the loop conformational flexibility) the trend of the 
thermal stabilities of T30695-r and-s GQ variants in different buffer conditions could be partially 
related to slight differences between Na+ and K+ GQ cores [42][86]. Indeed, NMR [86] and X-Ray 
[42] studies on GQs showed that potassium ions due to their relatively large radii reside between the 
G-quartet planes, coordinating the eight O atoms of G bases of two successive G-quartets. 
Conversely, the small Na+ ions can occupy a range of different positions inside the GQ core, 
including the G-quartet in-plane site. As a consequence of the ion mobility, the compactness of the 
GQ core is smaller in the presence of Na+ than K+. Therefore, the constrains related to the G-quartet 
distances and/or to the requisite coplanarity in each G-quartet could decrease with Na+ ions, thus 
allowing to similar stability of T30695-GQ and its r variants.  
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Conversely, the opposite orientation of the nucleobase in the S-glycerol T significantly affected the 
thermal stability of T30695-s GQs, in contrast with our previous results obtained from studies on 
TBA-GQs variants [58].Most probably, changes in parameters characterizing the GQ loops, such as 
the number of residues forming it, its spatial arrangement with respect to the GQ core, including its 
involvement in coordinating ions and/or water molecules, accounted for the characteristic behavior 
of T30695-s4, -s8 or -s12 GQ variants in presence of Na+. 
 
Results from gel electrophoresis assays reveal that all T30695 variants form GQ dimers in Na+ 
buffer. 
In order to verify the ability of T30695-r and -s variants to fold into 5'-5' end-to-end stacked GQs in 
the presence of Na+, non-denaturing gel electrophoresis mobility shift assay was performed. Figure 
27 shows the mobilities of T30695 (lane 2), of the T30695 variants (lanes 3-8), of TBA (lane 9) and 
of 5'-TT-T30695 (lane 1), on non-denaturing gel containing 50 mM of NaCl at r.t. (Panel A) and 
5°C (Panel B). TBA and 5'-TT-T30695 were used as internal reference for monomolecular GQs. 
The migrations of TBA and that of 5'-TT-T30695 [74][75] were faster than that of T30695, thus 
corroborating the hypothesis that folding of T30695 gives rise to dimeric GQ. T30695-r4 (lane 8), 
T30695-r8 (lane 6) and T30695-s12 (lane 3) migrated at the same extent of T30695, suggesting that 
these three variants preserved almost unchanged the ability of T30695 to form dimeric GQs. 
Smearing of T30695-r12 (lane 4), T30695-s8 (lane 5) and T30695-s4 (lane 7) occurred. This 
phenomenon was already observed and attributed to the formation of other dimer types such as, 3'-
3' end-to-end stacked GQ dimers [74][75]. T30695-s4 also showed a higher quantity of the fastest 
migrating band, that migrated similarly to 5'-TT-T30695, than the other species. According to CD 
results, these data suggested that, all the T30695 new variants were able to form, at least in part, GQ 
dimers.  
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A  
 
B  
 
Figure 27. Gel electrophoresis of oligonucleotides in 12% non-denaturing gel containing 50 mM NaCl at 25 (panel A) and 5°C 
(Panel B). 5'-TT-T30695 lane 1, T30695 lane 2, T30695-s12 lane 3, T30695-r12 lane 4, T30695-s8 lane 5, T30695-r8 lane 6, 
T30695-s4 lane7, T30695-r4 lane 8, TBA lane 9. 
 
 
Almost all T30695 GQ variants give rise to the same pattern of resonances in 1H NMR 
experiments with K+ or Na+ ions.  
The folding of nucleic acids into GQs can be qualitatively established by simple 1H NMR 
spectroscopy, because of the presence of characteristic imino (~10.0-13.0 ppm) and aromatic (~6.8-
8.0 ppm) proton resonances in the spectra [87]. Commonly, the number of imino and aromatic 
signals correlate with the folded GQ typologies, whereas the ratio between the intensity of imino 
and aromatic signals should correlate with the percentage of the nucleic acid sequence structured 
into GQs. Unfortunately, in the 1H NMR spectrum of T30695 GQ an extensive overlapping of both 
imino and aromatic proton signals appeared [74][75][88]. As a consequence, T30695 GQ 
characterization by NMR studies was previously performed introducing an Inosine residue instead 
of a G at a specific position [74][89]. This modification most probably causing the disruption of the 
structural symmetry, provoked the resolution of the proton signals in the spectra. Herein, each 
T30695 GQ variant contains a single modification at T loop, which leaved unaffected the shape and 
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the position of the T30695 GQ proton resonances (Figure 28). Despite this, the fact that the imino 
and aromatic regions of all 1H NMR spectra were almost identical for all the variants, with the only 
exception of the T30695-s4 GQ, suggested that almost all the new variants should keep unchanged 
the T30695 ability to fold into 5'-5' end-to-end staked dimers of parallel GQ. Notably, the imino 
proton resonance signals of the T30695-s4 variant were particularly crowded and extensively 
overlapped, that, could result from the presence of different species in the solution. 
In view of the ambiguous profiles of the CD-based heating/cooling curves obtained for some 
T30695 variants in the presence of Na+, that, partially or totally lacked the first inflection point, we 
selected the couple of T30695-r and -s12 GQs to acquire, in this saline buffered conditions, the 1H 
NMR spectra (Figure 29) at different temperatures (25-65°C). At 25 °C, the imino and the aromatic 
regions of the spectra showed almost the same patterns of proton resonance signals than that 
obtained in presence of K+ ions (Figure 28). Increasing the temperature from 25 to 65°C, the imino 
proton resonance intensities slowly decreased whereas the aromatic region of the spectra became 
more crowded. At temperatures higher than 45°C neither in T30695-r12 nor in T30695-s12, the 
shape and the position of the imino proton signals significantly changed, whereas new proton 
signals appeared only in aromatic region, thus suggesting that unfolded species were slowly 
forming in the solutions. Consistently with the absence of a clearly visible inflection point for 
T30695-s12 dimers in the CD heating/cooling curves, the two GQ events, 
dimers→monomers→unfolded appeared almost overlapped also in the 1H NMR heating 
experiments. This hypothesis was corroborated by our EMSA assays, (Figure 27) in which both 
aptamers showed the main band that migrated at the same extent of the T30695. 
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Figure 28. 1H NMR spectra in the range of 7.0-12.5 ppm of T30695 and its variants in K buffer (10 mM potassium phosphate, 10 
mM KCl, pH= 7.4). 
 
 
 
 
Figure 29.1H NMR spectra at different temperatures (25-65°C) in phosphate buffer solution (20 mM) containing 70 mM of NaCl.  
 
T30695-r12 T30695-s12 
55 
 
Mass spectrometry of aptamers confirm the ability of T30695 variants to form GQ dimers 
Molecularity of GQs can be studied by Electrospray Ionization Mass Spectrometry (ESI-MS) 
[90][91]. Indeed, ESI technique can preserve in gas phase GQs and/or GQ complexes formed in 
solution [92]. Generally, in order to analyze the GQs by ESI-MS, the ON samples are annealed in 
buffered solution containing ammonium ions. This because NH4
+, similarly to monovalent ions 
such as Na+ and K+, stabilizes the GQ core, by balancing the negative electrostatic forces generated 
by the oxygen atoms of the guanine bases arranged in G-quartets[93]. Most importantly, in the gas 
phase, the GQ should retain metallic cations both in the core and on the phosphate groups, whereas 
the ammonium ions are kept only in the GQ core. As a consequence of this specific inclusion, MS 
data can be related to the number (n) of G-quartets forming the GQ, according to the relationship n 
NH4
+→ (n+1) G-quartets[9][94]. 
In view of the poor resolution of proton resonances in the 1H NMR spectra, we used HRMS to 
corroborate the attribution of bands having slow electrophoretic mobility shifts to the end-to-end 
staked dimers of GQ monomers. Firstly, T30695 at 10 µM was annealed in buffer solution 
containing four different ammonium acetate (AA) concentrations, namely 25, 50, 75 and 100 mM.   
The MS experiments were performed by increasing the temperature of the capillary during the 
sample injection from 100 °C to 300°C. The analyses of the obtained spectra showed that while for 
the 100 and 75 mM AA solutions a heavy background noise hampered a clear interpretation of the 
full scan HRMS spectrum including assignment of elemental formula to each of the detected ions, 
at 25 and 50 mM AA solutions, much evidence could be obtained on the presence in gas phase of 
either the unfolded, the monomeric or the dimeric forms. (Figure 30, Table 4). 
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Table 4. Ion assignment of ions contained in full scan HRMS of T30695. 
 
Form m/z Ion 
Elemental  
Composition RDB Δ ppm 
DIMER      
 1469.1158 [2M+5NH4-12H]
7-
 C320H402O196N141P30 205.5     1.124 
 1472.2533 [2M+5NH4+Na-13H]
7-
 C320H401O196N141NaP30 205.5    -0.765 
 1475.3956 [2M+5NH4+2Na-14H]
7-
 C320H400O196N141Na2P30 205.5     0.607 
 
      1714.1347 [2M+5NH4-11H]
6-
 C320H403O196N141P30 205     0.183 
 1717.7994 [2M+5NH4+Na-12H]
6-
 C320H402O196N141NaP30 205     0.790 
 1721.4623 [2M+5NH4+2Na-13H]
6-
 C320H401O196N141Na2P30 205     0.348 
MONOMER      
 1026.3758 [M-7H+2NH4]
5-
 C160H198O98N70P15 104.5     0.715 
 1030.7726 [M+Na-8H+2NH4]
5-
 C160H197O98N70NaP15 104.5     1.111 
      
 1022.96934 [M-6H+NH4]
5-
 C160H195O98N69P15 105.5    -0.446 
UNFOLDED      
 1019.5655 [M-5H]
5-
 C160H192O98N68P15 106.5     1.033 
 1023.9614 [M-6H+Na]
5-
 C160H191O98N68NaP15 106.5     0.551 
      
 1274.7086 [M-4H]
4-
 C160H193O98N68P15 106     0.959 
 1280.20341 [M+Na-5H]
4-
 C160H192O98N68NaP15 106     0.427 
 1285.6988 [M+2Na-6H]
4-
 C160H191O98N68Na2P15 106     0.350 
      
 1699.9473 [M-3H]
3-
 C160H194O98N68P15 105.5     1.003 
 1707.2739 [M+Na-4H]
3-
 C160H193O98N68NaP15 105.5     0.580  
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Figure 30. Full HRMS spectrum of T30695 acquired at a capillary Temperature of a) 100°C, b) 200 °C and c) 300 °C. Ion 
assignments of unfolded, monomeric and dimeric ions are reported in Table 4. 
 
Indeed, the number of ammonium ions (either 2 or 5) associated with each ion peaks could be 
directly related to the presence of either the monomeric or the dimeric GQs, respectively (Figure 
30). Noteworthy, in MS spectra performed using 5’TT-T30695, which is known not to form GQ 
dimers, [77] only the mass peak patterns including 2 NH4
+ ions appeared (Figure 31 and table 5). 
Interestingly, T30695 at the minimum temperature (100°C) formed ions due to the monomeric 
forms [M+2NH4-7H]
5- and [M+NH4-6H]
5- in the region m/z 1000-1050 and ions due to the dimeric 
forms [2M+5NH4-12H]
7- and [2M+5NH4-11H]
6-in the region m/z 1400-1800 (Figure 30a). As the 
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temperature increased (200°C), the presence of ions due to the unfolded forms [M-nH]n- (n=3-5) 
arouse throughout the spectrum with the dimeric forms still present (Figure 30b). At the highest 
temperature (300 °C) only the unfolded forms were detected in the spectrum (Figure 30c). 
 
 
Table 5. Ion assignment of ions contained in full scan HRMS of 5’TT-T30695. 
 
Form m/z Ion Elemental  Composition RDB  ppm 
MONOMER 
     
 
1147.9932 [M+2NH4-7H]
5-
 C180H224O112N74P17 114.5    -0.245 
 
1152.1833 [M+2NH4+Na-8H]
5-
 C180H223O112N74NaP17 114.5 1.151 
 
1156.7857 [M+2NH4+2Na-9H]
5-
 C180H222O112N74Na2P17 114.5    -0.483 
 
1161.1815 [M+2NH4+3Na-10H]
5-
 C180H221O112N74Na3P17 114.5    -0.989 
 
     
 
1435.2425 [M+2NH4-6H]
4-
 C180H225O112N74P17 114    -0.816 
 
1440.73664 [M+2NH4+Na-7H]
4-
 C180H224O112N74NaP17 114    -1.747 
 
1446.23481 [M+2NH4+2Na-8H]
4-
 C180H223O112N74Na2P17 114     0.116 
 
1451.72898 [M+2NH4+3Na-9H]
4-
 C180H222O112N74Na3P17 114    -0.791 
UNFOLDED 
     
 
1141.1825 [M-5H]
5-
 C180H218O112N72P17 116.5    -0.317 
 
1145.57984 [M+Na-6H]
5-
 C180H217O112N72NaP17 116.5     0.515 
 
1149.97636 [M+2Na-7H]
5-
 C180H216O112N72Na2P17 116.5     0.627 
 
     
 
1426.73458 [M-4H]
4-
 C180H219O112N72P17 116     2.933 
 
1432.22805 [M+Na-5H]
4-
 C180H218O112N72NaP17 116     1.514 
 
1437.72271 [M+2Na-6H]
4-
 C180H217O112N72Na2P17 116     0.933 
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Figure 31. Full HRMS spectrum of 5’TT-T30695 acquired at a capillary Temperature of a) 100°C, b) 200 °C and c) 300 °C. Ion 
assignments of unfolded, monomeric and dimeric ions are reported in Table 5. 
 
Despite the trend of the peak pattern intensities as a function of the capillary temperature was only 
qualitative, the persistence of the dimeric GQ peak patterns over that of the monomeric ones at high 
temperatures, could be indicative of the robustness of the 5’-5’ staking interaction between the two 
T30695 GQ monomers, which appeared to strongly stabilize the whole GQ structure in the gas 
phase.  
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Finally, considering that the ammonium concentration used in the solution was almost unrelated to 
the relative intensity of the monomeric and dimeric GQs peaks (data not shown), 10 µM solutions 
of each T30695 variant were annealed in 75 mM AA and then diluted 1:3 with water. 
In order to provide evidence that ammonium ions did not significantly affect the T30695 GQ 
typology, the same MS samples were also analyzed by CD and CD melting experiments. As 
expected, the CD profiles of T30695 and its variants (Figure 32) resulted very similar to those 
obtained in presence of monovalent cations K+ or Na+, whereas the CD melting temperatures were 
in the range of 57-61 °C (Figure 33). 
 
Figure 32. CD spectra of T30695 and its variants annealed at 10 μM in 75 mM of acetate buffer and then diluted 1:3 with wather. 
TheCD profiles of GQ variants containing the R or S acyclic T residue are shown in the corresponding panel R or S. T30695 (black), 
T30695r-4and T30695s-4, (blue), T30695-r8and T30695-s8 (red), T30695-r12and T30695-s12 (green). Cuvette o.l. 0.5 cm. 
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Figure 33. 0-100 mdeg normalized CD melting experiments in ammonium acetate buffer. In all panels, blak line is referred to the 
CD melting profile of T30695, whereas continous or dotted blue line are referred to modified T30695 containing one R or S acyclic T 
residue at position 4 (Panel A) or 8 (Panel B) or 12(Panel C). The first derivatives of each melting curves was also reported in panels 
A', B' and C'. 
 
Full HRMS spectra of the T30695 R and S variants strongly resembled that of T30695 in 
distributions of ion forms (monomeric, dimeric and unfolded) at the different temperatures and 
relative ion ratios (Figure 34 and table 6). In more detail, for all the variants, with increasing 
capillary temperatures the unfolded species became gradually the dominant ion species. Despite the 
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MS data cannot account for the specific GQ typology, the overall acquired data strongly suggested 
that the introduction of one R or S acyclic T in place of T in the T30695 sequence did not 
significantly affect the ability of the resulting variants to form dimeric GQ by end-to-end staking of 
the monomers. 
 
Table 6. Ion assignment of ions contained in full scan HRMS of T30695-r8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Form m/z Ion 
Elemental  
Composition RDB Δ ppm 
DIMER      
 1457.1123 [2M+5NH4-12H]7- C316H398O194N141P30 203.5     1.555 
 1460.2473 [2M+5NH4+Na-13H]7- C316H397O194N141NaP30 203.5    -2.062 
  
     1700.1327 [2M+5NH4-11H]6- C316H399O194N141P30 203.0     1.725 
 1703.7941 [2M+5NH4+Na-12H]6- C316H398O194N141NaP30 203.0    -0.396 
MONOMER      
 1017.9744 [M-7H+2NH4]5- C158H196O97N70P15 103.5     2.499 
 1022.3704 [M+Na-8H+2NH4]5- C158H195O97N70NaP15 103.5     2.107 
      
UNFOLDED      
 1011.1626 [M-5H]5- C158H190O97N68P15 105.5     1.348 
 1015.5596 [M-6H+Na]5- C158H189O97N68NaP15 105.5     1.944 
      
 1264.2066 [M-4H]4- C158H191O97N68P15 105.0     2.342 
 1269.7020 [M+Na-5H]4- C158H190O97N68NaP15 105.0     2.264 
      
 1685.9443 [M-3H]3- C158H192O97N68P15 104.5     1.971 
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Figure 34. Full HRMS spectrum of the T30695 variant r8 acquired at a capillary Temperature of a) 100°C, b) 200 °C and c) 300 °C. 
Ion assignments of unfolded, monomeric and dimeric ions are reported in table 6. 
HIV_TR8_25mM_CH3COONH4 #153 RT: 4.49 AV: 1 NL: 5.40E3
T: FTMS - p ESI Full ms [800.00-1800.00]
800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
1457.8298
R=34804
z=?
1700.8026
R=32000
z=6
848.4783
R=46300
z=6
1018.3757
R=42200
z=5
926.8240
R=44200
z=3
1720.7946
R=31300
z=6
1264.7083
R=37500
z=4
1100.1818
R=41400
z=4
1043.5011
R=41101
z=3
1182.4441
R=36500
z=4
957.6497
R=45201
z=4
879.1316
R=44604
z=?
1297.4666
R=33701
z=4
1747.2966
R=27500
z=6
1569.9265
R=23204
z=?
1481.9629
R=27404
z=?
1642.5690
R=22104
z=?
1387.2130
R=29404
z=?
HIV_TR8_25mM_CH3COONH4 #307 RT: 8.92 AV: 1 NL: 7.59E3
T: FTMS - p ESI Full ms [800.00-1800.00]
800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
1264.7078
R=37500
z=41011.5644
R=42100
z=5
839.1440
R=46401
z=3
1704.2960
R=32100
z=6
926.4890
R=44201
z=3 1457.6855
R=34500
z=7
1036.5079
R=41800
z=3
1182.1932
R=39200
z=4
1099.9299
R=39700
z=4
1724.4570
R=31100
z=6
853.7985
R=44901
z=3 970.1499
R=43301
z=2
1286.4384
R=36000
z=4
1636.5968
R=32000
z=3
1357.2242
R=37400
z=3
1231.4480
R=37100
z=4
1569.2462
R=24904
z=?
1483.2418
R=30804
z=?
HIV_TR8_25mM_CH3COONH4 #418 RT: 12.01 AV: 1 NL: 1.48E4
T: FTMS - p ESI Full ms [800.00-1800.00]
800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
R
e
la
ti
v
e
 A
b
u
n
d
a
n
c
e
1264.7073
R=37600
z=4
1686.6125
R=32600
z=6
1011.5643
R=42100
z=5
1226.9447
R=38000
z=4970.1499
R=42801
z=2
1636.2622
R=32600
z=3
839.4783
R=46100
z=3 1036.5076
R=41900
z=3
1134.6764
R=39601
z=2
1705.2909
R=31800
z=6
1286.4381
R=37200
z=4
1585.9120
R=33700
z=3
1388.2355
R=37801
z=1
1466.9113
R=30301
z=3
1329.2030
R=39801
z=2
1748.9391
R=31604
z=?
A) T=100°C 
B)T=200°C 
C)T=300°C 
64 
 
LEDGF/p75 adversely affects the Integrase inhibitory efficiency of T30695 and its variants.  
With the aim to analyze how substantial differences between the Tm values of the T30695-GQs 
variants in the presence of Na+ ions could affect the aptamer anti-integrase activities, we performed 
LEDGF/p75 dependent and independent integration assays [95] under respective conditions (Table 
7). In the presence of LEDGF/p75 the IC50 value for T30695 was 146 nM (Table 7), whereas that of 
T30695 variants were in the range of 224-106 nM. The most favorable value (106±7.3) was 
obtained for T30695-s8. Two variants, T30695-r4 and T30695-s12, exhibited increased IC50 values 
compared with their unmodified counterparts, whereas the other variants and T30695 showed 
similar integrase inhibitory efficiencies. Comparisons of the CD melting temperature (Table 3) and 
the IC50(Table 7) values for modified aptamers containing the R or S acyclic T at position 4 or 8 
suggest the lack of correlation between GQ thermal stabilities and the integrase inhibitory activities. 
In fact, T30695-s4 and T30695-s8 GQs, which exhibited significantly decreased Tm values 
compared to the unmodified structure (ΔTm of -13 and -10 °C respectively, table 3), showed higher 
inhibitory potency (IC50 151±6.8 and 106±7.3 nM, respectively, table 4) than the corresponding 
T30695-r4 and T30695-r8 GQs (IC50 224±14 and 158±6.2 nM, respectively). Only in the case of the 
aptamers modified at T12 the loss of T30695-s12 GQ stability (ΔTm=-7 °C, calculated with respect 
to T30695) could account for the increased IC50 (220±9.6 nM) value. 
It is noteworthy that our measured IC50 value of T30695 was about 10-fold higher than that reported 
in literature [72][73][96], for this reason we performed also LEDGF/p75 independent integration 
assay;in the absence of LEDGF/p75 the inhibitory potencies of all aptamers significantly increased. 
Analyses of the IC50 values revealed that in all cases the aptamers modified with the S acyclic 
nucleotides showed slightly higher inhibitory activity than the corresponding R isomers. In 
addition, without LEDGF/p75 in the assay, the modifications at T8 with the R or S acyclic T had 
slightly improved the T30695 integrase inhibitory activity, whereas opposite trend was observed for 
T30695-r12 and T30695-s12. Overall these findings argue against positive correlation between the 
aptamer GQ stabilities and GQ integrase inhibitory efficiencies. 
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Finally, comparative analyses of ratios between the IC50 values measured for each aptamer with the 
two different assays, with or without LEDGF (+LEDGF IC50/-LEDGF IC50, table 7), as well as 
ratios between the IC50 values measured for each variant and that of T30695, in the presence or 
absence of LEDGF/p75 (-LEDGF, IC50variant/IC50T30695, +LEDGF, IC50variant/IC50T30695, 
table 7) also showed that LEDGF/p75 differentially affected the inhibitory potencies of aptamers, 
which varied depending on the position of modified nucleoside (4 or 8 or 12) and the chirality of 
modified nucleoside (R or S). Indeed, the ratio of IC50 values for each aptamer in the experimental 
conditions shifted from 5,0 (T30695-r12) to 11,0 (T30695-r8), whereas the IC50 values of new 
variants were from 0.7- up to 1,9-fold than that of T30695.  
Previous studies revealed that HIV-1 IN forms tetramers having distinct conformations depending 
on the presence of viral DNA or LEDGF/p75 in the solution and that the binding of LEDGF/p75 
modulates the structure of free IN and of IN/DNA complex [97][98][99]. Our findings suggest that 
the ability of LEDGF/p75 to stabilize specific HIV-1 IN tetramers also adversely affects the binding 
of T30695 and its variants and that the interactions between the three T loops of the GQs and HIV-1 
IN could be differently affected by the LEDGF/p75 binding to the HIV-1 IN.  
 
Table 7. IC50 values of T30695 and its variants measured in presence or in absence of LEDGF/p75.  
 
 
ON IC50 
LEDGF 
 Indipendent 
 (nM) 
 
 
IC50 
LEDGF 
Dependent  
(nM) 
+LEDGFIC50/ 
-LEDGFIC50 
-LEDGF 
IC50variant/ 
IC50T30695  
 
+LEDGF 
IC50variant/ 
IC50T30695 
T30695 16.68±2.62 146±6 9   
T30695-r4 30.15±3 224±14 7 1.8 1.5 
T30695-s4 24.49±4.1 151±6.8 6 1.5 1 
T30695-r8 13.9±1.9 158±6.2 11 0.8 1.1 
T30695-s8 11.75±3.75 106±7.3 9 0.7 0.7 
T30695-r12 31.52±1.74 151±8.1 5 1.9 1 
T30695-s12 27.79±6.32 220±9.6 8 1.7 1.5 
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3.3. Conclusion 
In this study, six new T30695 variants were synthesized with the acyclic R or S glycerol linker 
instead of deoxyribose unit at 4, 8 or 12 T residue. Based on our previous studies on TBA-GQ, this 
type of modification should provoke local changes in GQ conformations in the final T30695-GQ 
variants, that without affecting the structural stabilities could still potentially influence biological 
activities of aptamers.  
Our CD, 1H NMR, EMSA and HRMS studies showed that the new synthesized T30695 variants are 
able to fold in dimeric GQ structures that resemble that of T30695. Based on the number of 
ammonium ions incorporated into the GQ structure, the ability to form dimers for all T30695 GQ 
variants was confirmed by HRMS results carried out in the presence of ammonium acetate ions. In 
addition, in presence of Na+ ions, all T30695-GQ variants also had the same electrophoretic 
mobility as T30695-GQ, which in turn presented a lower electrophoretic mobility than 5'-TT-
T30695-GQ and TBA-GQ, which are known to form monomolecular GQ.  
CD heating and heating/cooling experiments also showed that the Tm values were always much 
higher in the presence of K+ ions than Na+ ions and that significant differences between the Tm 
values of T30695-r4, -r8, or -r12 and the corresponding T30695-s4, or -s8, or -s12 GQs were 
noticeable mainly in the presence of Na+. Finally, the HIV-1 IN inhibitory activities of T30695 
variants, annealed in the presence of Na+ ions, were evaluated using LEDGF/p75 dependent and 
independent assays. Our data support the hypothesis that LEDGF/p75 is able to negatively 
modulate the binding of T30695 and its variants to HIV-1 IN tetramers. Indeed, the obtained results 
showed that: i) the stability of T30695-GQ variants only marginally affects their ability to inhibit 
HIV-1 IN activity; iii) addition of LEDGF/p75 in the assay substantially reduced (about 10-fold) the 
ability of T30695 to inhibit HIV-1 IN; iv) LEDGF/p75 also affected the inhibitory efficiencies of 
T30695 variants, but the extent of this effect depended on the position and the chirality (R or S) of 
glycerol T loop in the GQ; iv) T30695-s8 consistently exhibited better inhibitory efficiency than 
T30695. Despite more in depth studies should be performed to clarify the role of LEDGF/p75 in 
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determining the T30695 inhibitory efficiency against HIV-1 IN, our results are relevant for the 
assessment of the molecular factors that contribute to the true effectiveness of G-quadruplex 
forming aptamers as inhibitors of HIV-1 IN. 
 
3.4. Experimental section 
Chemicals and anhydrous solvents were purchased from Fluka-Sigma-Aldrich. TLCs were run on 
Merck silica gel 60 F254 plates. Silica gel chromatography was performed using Merck silica gel 
60 (0.063–0.200 mm). Reagents and phosphoramidites for DNA syntheses were purchased from 
Sigma-Aldrich. ON syntheses were performed on a PerSeptive Biosystem Expedite DNA 
synthesizer. HPLC purifications and analyses were carried out using a JASCO PU-2089 Plus HPLC 
pump equipped with a JASCO BS-997-01 UV detector. CD experiments were performed on a 
JASCO 715 spectropolarimeter equipped with a PTC-348 temperature controller. NMR data were 
collected on Varian UNITYINOVA 500 MHz spectrometers equipped with a broadband inverse probe 
with z-field gradient and on a Varian UNITYINOVA 700 MHz spectrometer equipped with a triple 
resonance cryoprobe. The data were processed using the Varian VNMR and the NMR 
(http://www.inmr.net) software packages. Mass spectrometry data were collected on a hybrid linear 
ion trap LTQ Orbitrap XL™ Fourier Transform MS (FTMS) equipped with an ESI ION MAXTM 
source (Thermo-Fisher; San Josè, CA, USA).  
Synthesis of oligomers 
T30695 and its variants were synthesized using standard solid phase DNA chemistry on a  
controlled pore glass (CPG) support 3’-bounded to the first nucleotide of the sequence, following 
the β-cyanoethyl phosphoramidite method[54]. Modified phosphoramidite building block was 
obtained as previously described[58]. The coupling time of modified monomer was prolonged from 
2 to 15 min. The oligomers were detached from the solid support and deprotected by treatment with 
an aqueous ammonia solution (33%) at 55 °C overnight. The combined filtrates and washings were 
concentrated under reduced pressure, dissolved in H2O, and purified by HPLC using an anionic 
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exchange column eluted with a linear gradient (from 0% to 100% B in 30 min) of phosphate buffer 
at pH 7.4 (A:20 mM NaH2PO4 aqueous solution containing 20% CH3CN; B: 1.0 M NaCl, 20 mM 
NaH2PO4 aqueous solution containing 20% CH3CN, elution time 19 min). The oligomers were 
successively desalted by molecular exclusion chromatography on Biogel P-2 Fine. The purity 
(95%) was checked by 1H NMR spectra acquired in D2O. The concentrations of the samples used in 
CD and UV experiments were determined by measuring the absorbance at 260 nm at 80 °C and 
using the open access program available on http://basic.northwestern.edu/biotools/OligoCalc.html 
[64]. 
CD, CD heating and heating/cooling experiments 
To perform the CD experiments, each ON was dissolved in K buffer (10 mM KCl, 10 mM 
potassium phosphate buffer, pH 7.4), PBS (Sigma-10 mM phosphate buffer, NaCl 138 mM; KCl 
2.7 mM, pH 7.4), Na buffer (10 mM sodium phosphate buffer, 60 mM NaCl, pH=7,4) or 
ammonium acetate buffer (75 mM, NH4CH3COO) at the final ON concentration of 2.0 × 10
−5 M 
and submitted to the annealing procedure (heating at 90 °C for 5 min and slowly cooling at r.t.). 
Before each experiment, the samples were equilibrated at 10 °C for 15 min. In ammonium acetate 
buffer (75 mM), the ON concentration was of 34 μM. After annealing, the samples were diluted 
with water to reach about 11 μM of ON and 25 mM of ammonium acetate.  
CD spectra were recorded from 200 to 400 nm at 100 nm min−1 scanning rate, 16 s response, 2.0 nm 
bandwidth, cell length 0,1 cm, V=400 μL. Each CD profile was obtained by taking the average of 
three scans.  
CD heating and heating/cooling curves were obtained by monitoring the variation of absorbance at 
263 nm from 10 to 90 (or 100) °C [ON] = 2.0 × 10−5 M, cell length 0.5 cm, V=1400 μL, 
temperature scan rate 0.2 °C min-1. The resulting curves were processed using the adaptive 
smoothing (convolution width 25). Each heating/cooling curve was acquired in triplicate. For each 
T30695 variants, T1/2 and Tm values were calculated from the two minima of the first derivatives of 
the heating curves. The average of three values and the Standard Error were reported in Table 3. 
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1H NMR experiments  
NMR samples were prepared in the same K or Na buffer used for CD experiments, containing 10 
%(v/v) /D2O at a single strand concentration of about 4 mM. At each showed temperature, the 
1H 
NMR spectra were acquired as 16,384 data points with a recycle delay of 1.2 s. All spectra were 
recorded using pulsed-field gradient DPFGSE for H2O suppression. Data sets were zero filled to 
32,768 points prior to Fourier transformation and apodized with a shifted sine bell squared window 
function. 
Electrophoresis gel shift assay 
ONs were annealed in Na buffer. The samples, with a total strand concentration of 0,2 O.D.x μL 
(100 μL), were heated to 90°C, gently cooled at r.t., than incubated at 20°C for two days. 2 µL of 
each solution were diluted with 4 µL of loading buffer (50% glycerol, 50% Na buffer,v:v) and 
loaded and ran on 12% non-denaturing polyacrylamide gels in 1XTBE buffer containing 50 mM of 
NaCl. The electrophoresis were ran at 5°C or 25 °C for 4 h at 120 V. The gel was visualized by UV 
lamp.  
High Resolution Mass Spectrometry experiments 
Oligonucleotides were annealed in 100, 75, 50, and 25 mM ammonium acetate buffer with a total 
strand concentration of 3 O.D. x mL (1 mL). The samples were directly infused into the HRMS 
instrument at 5 mL/min. The oligonucleotides annealed in 75 mM ammonium acetate buffer was 
further diluted with distilled water to a total strand concentration of 1 O.D. x mL (1 mL). Full scan 
HR MS experiments were acquired in negative ion mode in the mass range m/z 800-1800 at a 
resolving power of 60,000 (FWHM at m/z 400). The following source settings were used: a spray 
voltage of 3 kV, a capillary temperature in the range 100-300°C, a capillary voltage of -90 V, a 
sheath gas and an auxiliary gas flow of 40 and 1 (arbitrary units), respectively. The tube lens 
voltage was set at -150 V. Calculation of elemental formula was performed on the mono-isotopic 
peak of each ion cluster using Xcalibur software version 2.0.7 with a mass tolerance of 3 to 5 ppm. 
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The isotopic pattern of each ion cluster was taken into consideration in the assignment of molecular 
formula. 
LEDGF/p75 dependent and independent integration assays 
Previously developed homogenous time-resolved fluorescence (HTRF) technique [97] was used to 
determine IC50 values of aptamers for both LEDGF/p75 dependent and independent integration 
activities. The ONs (lyophilized powers) were dissolved in phosphate buffer solution containing 70 
mM of Na+ ions at pH=7 (at final ON concentration of 5 mM). The solutions were then annealed by 
heating at 95˚ C for 5 minutes and slowly (7-8 hrs) cooled down to room temperature. The ON 
solutions were serially diluted with buffer. For each ON, the highest stock concentration tested was 
1mM which gave the final concentration of 20uM in the assay.100 nM IN was incubated with 
varying concentrations of aptamers for 1 hour at room temperature in the reaction buffer containing 
20mM Hepes (pH 7.5),1mM DTT, 10 mM MgCl2, 10% glycerol, 0.05% Brij-35, and 0.1 mg/mL 
BSA. Then integration reactions were initiated by addition of 50 nM 5’-Cy5 labelled 21-mer viral 
DNA and 10 nM 3’-Biotinylated target DNA and incubated for 3 hours at 37°C. For LEDGF/p75 
dependent assay also 100 nM LEDGF/p75 was added to the reaction. For detection of the reaction 
products 2nM Eu-SA antibody in the detection buffer (20 mM EDTA, 0.05% Brij-35, 1mg/mL 
BSA and 1M NaCl) was added to the reaction mixture at the 1:1 ratio and incubated overnight at 
4°C. The HTRF signal was recorded by PerkinElmer EnSpire multimode plate reader. 
 
This work has been submitted for publication.  
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Part II 
1. Introduction 
1.1. Azobenzenes as molecular photoswitchers 
Nowadays, molecular switchers attract great interest in view of the fascinating challenge to reach 
the spatial and temporal control of chemical and/or biological processes. Light is the ideal external 
reagent trigger for in situ chemical and biological processes, because: i) it provides high selectivity 
and does not cause the sample contamination; ii) it is generally non-invasive within specific 
wavelength; iii) it can be regulated qualitatively and quantitatively, adjusting its wavelength and 
intensity, and iv) it can be delivered with very high spatial and temporal precision [1]. 
Photoresponsive molecules (“Photoswitchers”) exhibit two forms, differing from each other for 
their chemical-physical properties. Upon irradiation with a light tuned on specific wavelengths, the 
stable form may reversibly convert into metastable one. One of the most attractive application of 
photoswitchers concerns the dynamic photocontrol of drug activity. Indeed, being the 
pharmacodynamic and pharmacokinetic properties of drugs directly related to their molecular 
structure, exploiting photoinducible structural changes, the therapeutic action of photoresponsive 
agents should be finely controlled. 
The most common photoswitchers are: azobenzenes and stilbenes, which undergo cis–trans 
isomerisation; diarylethenes and spiropyrans which interconvert between open and closed forms 
(Figure 1). 
The largest and most investigated class of photoswitchers are the azobenzenes, which present two 
aromatic rings linked by azo group (N=N) and can exist in two isomeric states, trans and cis, with 
the former being ∼10 kcal/mol more stable than the latter. The readily isomerization of the N=N 
double bond by a light source and the easiness of synthesis of many derivatives make azobenzenes 
good candidates for various applications from materials science to neurobiology. Originally, azo 
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compounds were used as synthetic colouring agents in the dye industry, their discovery dates back 
to 1800 [2][3]; a high number of chemical-physical studies have been performed in order to 
evaluate the fluctuation of photoresponsive properties in different sets of variously functionalized 
azobenzenes, including the introduction of multiple diazo moieties, the use of diverse aromatic 
rings and/or diverse substituents on aromatic rings [3][4][5]. 
 
 
Figure 1. Molecular Structures of Photoswitchers. 
 
The trans azobenzene is 10–12 kcal mol-1 more stable than the cis isomer, accordingly, in the dark, 
at equilibrium, trans is the dominant isomer (˃99.99%). The trans and cis azobenzenes differ from 
each other in polarity, molecular geometry and absorption spectrum. The trans isomer is almost 
planar and has a dipole moment near to zero, in contrast the cis isomer is twisted ≈55° out of the 
plane and has a dipole moment of 3 Debye (Figure 2). 
The cis-trans azobenzene isomerization process also causes the decrease of distance, from 9.0 Å to 
5.5 Å between the two carbons in para positions. 
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Figure 2. Photoisomerization process of azobenzene [from Beilstein J. Org. Chem., vol. 8, pp. 1071–1090, 2012]. 
 
The UV–vis spectra of cis/trans azobenzene differ from each other [3] (Figure 3). Trans-
Azobenzene shows a weak n→π* band around 440 nm and a more intense π→π* band near 320 
nm; whereas the UV spectrum of the cis-azobenzene shows a more intense n→π* band than that of 
the trans form, and other absorption bands at 280 nm and 250 nm. The transition π→π* is usually 
in the near UV region, while the electronic transition n→π* is usually located in the visible region 
and is due to the presence of unshared electron pairs of nitrogen atoms [6]. 
 
Figure 3 The UV-vis spectra of the trans and cis isomers of azobenzene [from Chem. Soc. Rev., vol. 40, no. 8, pp. 4422–4437, 
2011].  
 
Thanks to the differences of the cis/trans adsorption bands, the irradiation with a light tuned on a 
specific wavelength allows the cis/trans photochemical conversion. The wavelength suitable to the 
conversion is dependent on both the nature and the position of the substituents of the aryl groups 
[3][7]. 
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The trans-azobenzene easily isomerizes to the cis isomer by irradiation with a light tuned on 320–
350 nm. The trans isomer is renovated reversibly irradiating the cis isomer with a light tuned on 
400–450 nm, or spontaneously in the dark. The cis/trans photoisomerization of many azobenzenes 
occurs on the scale of picoseconds, while in other cases the thermal relaxation of the cis isomer to 
the trans isomer is slower (from milliseconds to days) [3]. 
The mechanism of photoisomerization of trans azobenzene has attracted interest for many years and 
is today still under investigation [8][9][10]. 
In the UV-visible spectra of the molecule the two major absorption bands correspond to n→π* 
electronic transition (S0→ S1) with the maximum intensity near 440 nm and to π→π* electronic 
transition (S0→S2) with the maximum intensity near 320 nm. 
Excitation of these two electronic states imply two different isomerization mechanisms; visible 
excitation to the S1(n,π*) state leads to the isomerisation via inversion around one nitrogen atom in 
the same molecular plane, whereas UV excitation to the S2(π,π*) state leads to the isomerisation via 
the rotation around the NN double bond (Figure 4) [11][12]. 
 
Figure 4. Inversion and Rotation Mechanisms of trans-azobenzene. 
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1.2. Modulating Azobenzenes photoisomerization for in vivo use 
 
Pharmacotherapy aims to treat diseases and alleviate symptoms through the administration of drugs; 
however, poor drug selectivity can induce side effects and drug resistance. These restrictions should 
be predictable considering the affinity of drugs for more than one biological targets, being, the 
latter, involved at different stage of complex signalling and metabolic pathways. A possible solution 
to these problems could be the control of drug action in time and in space by light [13][14], 
achievable through the design and the synthesis of photopharmacological agents, whose 
pharmacodynamic and pharmacokinetic properties can be modified through photoinduced changes 
in the structure. In order to develop optically controlled drugs azo compounds are good candidates 
in view of their easy, quantitative and reversible cis–trans photoisomerization. 
Very recently, some azobenzene derivatives have been reported as potential anti-cancer agents. 
Indeed, the main aim of the cancer research is the finding of selective and specific inhibitors of 
cancer cells growth, leading to a drastic reduction of systemic side effects. Being the 
pharmacological action of these azocompounds "photoregulated", the spatial-temporal control of 
their biological action can be triggered by light. The second part of my research activity has been 
performed in this fascinating field and such preliminary results are reported in the next two 
chapters. 
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2. Azobenzene Photoswitchers as anti-cancer tools 
2.1. Photo-control of cancer cell growth by N-substituted pyrrol azo-derivatives  
Currently, among the most clinically used chemotherapeutics are Microtubules (MTs) inhibitors, 
such as Taxol and the Vinca alkaloids. Microtubules are involved in several cellular processes, 
including intracellular transport, cell motility, and mitosis, therefore treatment with microtubule 
directed drugs often leads to serious systemic side-effects, such as cardiotoxicity and neurotoxicity.  
Mostly, it has been discovered that PSTs (Figure 5) could be an efficient alternative to colchicines 
and combretastatins, as tubulin and MTs directed drugs, since, being their action controlled by local 
and specific irradiation, the side effects associated with MTs depolymerization in normal cells can 
be, potentially, avoided. [15][16]. PSTs were designed as Combretastatin A-4 analogs only 
changing a double C bond in to a double N bond. Their affinities towards MTs colchicine binding 
site were turned on by irradiation of the stable trans isomers into the corresponding cis. 
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Figure 5. Natural ligands of MTs and AzD analogs.  
 
In this frame, the large number of Combretastatin A-4 analogs discovered in the last years [17][18], 
modified at phenyl rings and/or at double carbon bond, suggest that the exploration of different 
typology of AzB analogs as potential photo-activable inhibitors of cancer cell growth should be 
achievable. Literature data highlight that etheroarene diazo derivatives showed interesting optical 
properties, in view of their ability to switch from the trans to the cis form by irradiation with low 
light intensity having red-shifted wavelengths, respect to that occurring for un-substituted AzB [19]. 
Furthermore, the regioselective reactivity at cabon 1 of N-substituted pyrrole derivatives in reaction 
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with azonium salts, should increase both the number of synthesizable Azo dyes, obtainable by 
replacing the substituent at nitrogen atom of pyrrole ring, and the yields of the coupling reaction, 
avoiding the formation of different regioisomers [17]. 
In order to explore the potentiality of azo-heteroarene typology as cancer cell growth inhibitors, we 
synthesized the 1a/1b molecules (Figure 5), that were successively studies for their physical and 
biological properties. Based on the promising photo-activable antiproliferative action on HCT p53-/- 
cancer cells (see below) the mixture 1a was successively reproduced as pure stereomers 1RR and 
1RS. 
 
2.2. Results 
Synthesis of 1a, 1b and 1RR, 1RS. 
The four synthetic steps were performed starting from 4-nitrophenol (Figure 6), which was coupled 
with R or S glycidol in presence of catalytic amount of KOH, to obtain the intermediates 2 [20]. 
Reduction of 2, as R or S stereomer, with H2/Pd (C) and successive conversion of the amino- to the 
diazonium-group gave rise to 4R or 4S, each of them was finally coupled with racemic methyl 3-
hydroxy-2-(1H-pyrrol-1-yl)propanoate 5. The best yields of the coupling step were obtained 
quenching the reactions after 1h from the mixture. 
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Figure 6. a) 4-nitrophenol, (0.500 g, 3,6 mmol), KOH (1 mg, 1,8x10-2 mmol), dry toluene (2 mL) 30 min under reflux. 287 µL of R 
or S glycidol (0,320 g, 4,3 mmol) was added at r.t., then heated at 90°C for 24h. b) 2 (R or S, 0.560 g, 2,6 mmol), Pd/C (28 mg), 25 
mL di EtOH (90%, HPLC grade) were stirred 2 h in a Parr apparatus under H2 (P= 400 psi). c) a mixture of 3 (0,400 g, 2,2 mmol), 
205 µL fluoroboric acid (water solution, 48%,3,3 mmol ), EtOH (4 mL) was cooled at -15°C under argon, 224 µL of isoamyl nitrite ( 
0,258 g, 2,2 mmol) were added and the reaction was kept at r.t. 12h. d) 4 (0,360 g, 1,8 mmol), 10 mL of acetic acid (14 g, 232 mmol), 
sodium acetate (4,0 g, 511mmol) and 5 (rac or R or S) (254 µL, 0,270 g, 2,2 mmol) were kept 1 h at r.t., under slow stirring to give 
1a, or 1b, or 1RR or 1SS (yields 58-59%). 
 
The final diastereomeric mixtures 1a and 1b, as well as the pure 1RR and 1RS, and/or 
intermediates were characterized by mono- and bi-dimensional HRMS, NMR, and UV. 
 
UV-Vis spectroscopy  
UV spectra of the thermodynamically stable trans 1a and 1b were performed in three different 
solvents, MeOH, H2O and Phoshate Buffer Solution (PBS). In order to obtain data related to the 
trans isomer, the cuvette (0.1 o.l. Vol. 400 μL) containing 40 or 80 μM of 1a or 1b in MeOH was 
taken in dark at r.t. for about 12 h 
 In all examined conditions the UV profiles (Figure 7A) of both species were almost super 
imposable, showing, in H2O and Phoshate Buffer Solution (PBS), two major broad bands, with 
similar intensity, centered at 391 and 430 nm whereas in MeOH the relative intensity of the same 
two bands was appreciably different. After light exposition (435 nm), the UV profiles of trans 1a 
and 1b strongly changed to give rise to the cis 1a and 1b UV spectra, showing a significant 
decreasing of the band intensities in the range 350-460 nm, the occurrence of a new band centered 
at about 340 nm (Figure 7B, line blue) and a broad absorption band that extended over than 475 nm. 
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Figure 7. Panel A: UV spectra of 1a in MeOH (black), PBS (blue) and H2O (violet). Panel B: UV spectra of 1a in MeOH before 
(green) and after (blue) irradiation at 435 nm. 
 
The cis 1a/b thermal decay was monitored by further sequential acquisition of spectra until the UV 
profile rice to that of the initial trans isomer (Figure 8). In order to obtain t1/2 of cis isomer, after the 
sample irradiation with light at 435 nm, UV time course measurement experiments were performed 
monitoring the absorbance values at 340, 390, 425, 400 and 505 nm, number of cycle 100-180, 
cycle time 60 sec (Figure 9-10-11-12). 
In both type of experiments, the intensity of UV band at 390 nm were almost restored into about 40 
or 10 min in the case of 1a and 80 or 10 min for 1b, depending on the solvent conditions (MeOH or 
PBS, respectively). All the collected UV data strongly suggested that irradiation of samples with 
violet light induced the conversion of the thermodynamically stable trans 1a/b to the corresponding 
metastable cis, and that cis to trans reversion occurred in dark. 
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Figure 8. Time-dependent UV spectra of 1a (2 min) after irradiation at 435 nm. 
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Figure 9. Time-dependent absorption after irradiation of 1a measured in MeOH at 390 and 345 nm. Panel A [1a] = 80 μM; panel B 
[1a]= 40 μM 
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Figure 10. Time-dependent absorption after irradiation of 1a measured in PBS at 390 and 345 nm. Panel C [1a] = 80 μM; panel D 
[1a] = 40 μM 
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Figure 11. Time-dependent absorption after irradiation of 1b measured in MeOH at 390 and 345 nm. Panel A [1b] = 80 
μM; panel B [1b]= 40 μM 
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Figure 12. Time-dependent absorption after irradiation of 1b measured in PBS at 390 and 345 nm. Panel C [1b] = 80 μM; 
panel D [1b]= 40 μM. 
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1H NMR experiments 
To gain further insight about the photo-conversion properties of 1a, we also analysed the 
proceeding of cis to trans conversion by acquiring 1H NMR spectra in dark and at different times 
from the irradiation at 435 nm. In dark, the 1H NMR spectrum of 1a (Figure 13) in the range of 7,6-
5.5 ppm showed five aromatic proton resonances at 7,70, 7,28, 7,04, 6,67, 6,32 ppm and the proton 
on α-C of methyl-ester at 5,62 ppm.  
 
 
 
 
 
 
 
 
 
 
After light exposition of the sample, beside the proton resonances attributed to the trans 1a (Figure 
13), a new set of five signals appeared in the same region of the spectrum (Figure 14). Over time, 
the intensities of the new signals strongly decreased, and the 1H NMR spectrum evolved towards 
that obtained for 1a kept in dark. Therefore, the transient proton signals can be related to the 
metastable cis 1a, activated by led light at 435 nm. 
Figure 13. 1H NMR spectrum of 1a in CD3OD 
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Figure 14. 1H NMR spectra of 1a in the range of 7.9-5-5 ppm, sequentially acquired after irradiation at 435 nm. Transient resonances 
signed by an asterisks were produced by the protons of the metastable cis 1a. 
 
Possible methyl ester hydrolysis 
We tested the occurrence of the hydrolysis of methyl ester group of 1a/b dissolved in PBS at r.t. 
During the first 2 days, nor hydrolyzed or degraded product was observed by TLC plate. After 5 
days from dissolution, a mass spectrum corresponding to the hydrolyzed products (6a/b, figure 15) 
we recovered (see experimental section).  
 
Figure 15. Schematic representation of the hydrolysis of 1a. 
 
UV spectra performed before and after irradiation of 6a/b in PBS showed a substantial decreasing 
in the half life time of the corresponding metastable cis forms. Indeed, UV spectra measured after 
irradiation, showed only slightly difference with that measured in dark. In order to quantify the half 
life time of cis 6a/b stereomers, in collaboration with professor C. Altucci (Department of Physic, 
University of Studies Federico II, Naples), we performed kinetic measurements for photo-
conversion of the trans 6a/b (in PBS and H2O) and 1a/b (in methanol) to the cis isomers, and for 
the thermal relaxation in dark by UV fast spectroscopy (Figure 16). An exponential decay model is 
used to fit on the measured data and the half-life times (t1/2) for trans 1a, 1b, 6a and 6b to their cis 
O
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forms, moreover also the reverse cis to trans conversion are deduced, and reported (Figure 16B). 
Samples are made by dissolving 1a/b molecules in different solvents: Methanol, H2O and PBS. 6a 
and 6b are produced as a result of hydrolysis of the 1a/b in water-based solutions. After five days 
from dissolution, the measured half-life time of cis 1a/b in methanol had similar values than that 
measured by UV spectroscopy (Figure 16A and B). In contrast, in PBS solutions cis 6a/b showed a 
decreasing in t1/2 of about 4-7-fold respect to that of cis 1a/b. 
 
 
 
 
 
 
 
 
Figure 16. Panel A. Table showing half-life times of 1a/b and their hydrolyzed derivatives 6a/b measured with fast UV 
spectroscopy. Panel B. An example of 404-nm probe intensity changes: passing through 1b in methanol solution as a function of 
time; (a) trans to cis conversion [when laser is on and the sample is being irradiated with 10 mW, 435 nm laser beam], and (b) cis to 
trans conversion [in dark]. 
 
Samples are made by dissolving 1a and 1b molecules in different solvents: Methanol, H2O, and 
PBS. 6a and 6b are produced as a result of hydrolysis of the 1a/b in water-based solutions. 
Then, 2 mL of the sample is hold in a quartz cuvette, stirred by a magnetic stirrer; and transmission 
percentage at 404 nm in 10 mm optical path is monitored. A sketch of the optical setup for this 
experiment is shown in figure 17. A Mercury-Argon lamp is used as the light source of 404.6 nm. 
  
Solvent 
Trans→Cis 
(λ=435 nm) 
sec 
Cis→Trans  
(Dark) 
sec 
1a Methanol ~ 5  444  
6a PBS ~ 5  40 – 45  
Water ~ 5  10 – 15  
1b Methanol 5.6  1026  
6b PBS 6  78  
Water 4  120  
A 
B 
94 
 
Several optical filters are used to filter out other wavelengths and reduce 404 nm average power, 
preventing any perturbation of the sample with the probe light. A couple of UV-grade convex lenses 
are used to collimate diverging output light of the lamp and finally couple it to an optical fiber that 
conveys the light to the detector. The cuvette is kept between the two lenses and collimated 404 nm 
light is passing through the sample. The detector is a spectrograph combined with an intensified 
CCD (ICCD), which is recording the transmitted light at a repetition rate of 2 Hz. 
 
 
Figure 17. The optical setup for the UV fast spectroscopy. 
 
435 nm laser beam is used to induce trans to cis reactions. This 435-nm laser beam is generated by 
an ORPHEUS optical parametric amplifier that is pumped by 1030-nm fundamental pulses emitted 
at 2 kHz repetition rate by a custom version of a PHAROS laser source. PHAROS output power is 
about 1.7 W and leads to ~ 10 mW laser beam at 435 nm generated in ORPHEUS. This laser beam 
is then passing through the sample with a small angle with the 404-nm probe. Transmitted 404-nm 
power is registered during the 435-nm irradiation to deduce trans to cis half-life time. In the next 
step the 435-nm laser is turned off to monitor the reverse reaction in dark (Figure 17). 
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Light-dependent cytotoxicity 
The light-dependent 1a and 1b cytotoxicity was evaluated by MTT test on the HCT p53-/- cell line. 
Keeping 1a/b in the dark regime, the cytotoxic effects of trans 1a/b were assayed, while applying 
short illumination impulses (50 ms ON/1 min OFF of 435 nm LED light) by a hand-built LED 
lighting system (Figure 18), the cytotoxic effects of cis 1a/b were assayed. 
Taking as a reference the LED lighting system built by Borowiak and co-workers [15], also we 
hand-built it to illuminate separately the 96-well cell culture plates with independent wavelengths.  
 
Figure 18. Led lighting system. A) Array with LED at 505nm, B) Array with LED at 435nm, C) Arduino 
 
Specifically, the LED lighting system consists of arrays of LEDs at specific wavelength (435nm 
and 505nm) and connected in parallel (Figure 18). Each array irradiated a 96-well cell culture plate 
separately during the cell viability experiments (MTT test) and at same time was kept in incubator 
(37°C and 5% CO2) (Figure 19). 
The LED lighting system uses a programmed microcomputer (Arduino) to operate timing impulse 
patterns (50 ms ON/1 min OFF of 435 and 505 nm LED light) of LEDs arrays. 
 
A B C 
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Figure19. Irradiated 96-well cell culture plates at 505nm (A), and at 435nm (B). 
 
In collaboration with prof. Giulia Russo of the University of Naples Federico II, MTT test of 1a and 
1b was performed on the HCT p53-/- cell line (Human Colon Carcinoma cell line) at two 
concentrations (1 and 10 µM) (Figure 20).  
 
 
Figure 20. Cytotoxic effect on HCT p53-/- cell line of 1a and 1b in dark regime at 1 and 10 µM.  
 
The HCT p53-/-cell growth differently responded to the treatment with the two diasteoreomeric 
mixtures 1a or 1b both in dark and under led irradiations. Indeed, in dark (Figure 20), at 
concentration of 1 μM, both 1a/b resulted almost ineffective on cell growth. Used at 10 μM, the 
antiproliferative activity showed by 1b was considerably higher than that of 1a. Furthermore, cells 
were treated with 1a or 1b undergoing irradiation at 435 or 505 nm during 12h. Based on half-lives 
Illuminated Multi-well plates are kept in incubator (37°C and 5% CO2)  
 
A B 
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of 1a/b and 6a/b in PBS (Figures 10-12) we used a pulse-program 50 ms-ON/ 1,0 min-OFF by 
means of a Led light system. Led irradiation at used wavelengths resulted almost ineffective on 
viability of untreated cells. However, we observed a four-fold higher antiproliferative efficiency of 
1a in the presence of light at 435 nm, respect to the treated control in dark, at both used 
concentrations (Figure 21). Under the same wavelength irradiation, the cells treated with 1b at 1 
μM showed a growth decreasing of about 20%, whereas at 10 μM, 1b caused almost the same cell 
growth inhibition than in the dark. Irradiation at 505 nm only slightly effected cell growth treated 
with 1a but caused a complete reversion of the antiproliferative effect of 1b in dark. Therefore, 1a 
showed a significant photo-induced increasing of the potency of its antiproliferative action only 
under irradiation at 435 nm.  
 
 
Figure 21. Cytotoxic effect on HCT p53-/- cell line of 1a and 1b at 1 and 10 µM illuminating at 435 and 505 nm. No Treated = cells 
no treated and illuminated at 435 and 505nm separately. 505nm = cells treated and illuminated at 505nm compared to the cells no 
treated and illuminated 505nm. 435nm = cells treated and illuminated at 435nm compared to the cells no treated and illuminated 
435nm. 
 
In view of their promising photo-responsive antiproliferative activity, the stereospecific synthesis of 
the two stereomers forming 1a, was performed (Figure 6). Time-dependent UV experiments 
revealed that the half-lives of cis 1RR and cis 1RS in PBS were slightly diverse (5,8 and 4,2 min, 
respectively, figure 22), whereas the average of the two values corresponded to that of 1a (Figure 
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10). 1RR and 1RS also differed in their CD profiles, both showing a Cotton effect centered at about 
400 nm but having almost opposite signature (Figure 23), and could be separated on chiral column 
by HPLC (Figure 24). However, the two diastereomers showed the same 1H and 13C NMRs.  
 
Figure 22. Time-dependent absorption of 1RR and 1RS in PBS after irradiation. Data were collected at 390 (absorption of the trans 
form) and 345 (absorption of cis form) nm. Panel A [1RR] = 80 μM; panel B [1RS]= 80 μM. 
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Figure 23.CD spectra of 1RR (blue line) and 1SS (green line) measured in MeOH. o.l. 0.5 cm, Vol= 1400 μL. each compound was 
used at final concentration of 80 μM. 
 
Figure 24. HPLC chromatograms of 1RR and 1RS on chiral column Lux 3u Cellulose-3 eluted with n-hexane:propan-2-ol (80:20) 
Flow: 1.0. 1. mixture of the two diastereomers 1a; 2. 1RR; 3. 1RS. 
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2.3. Experimental section 
 
General procedure 
Chemicals and anhydrous solvents were purchased from Fluka-Sigma-Aldrich. TLCs were run on 
Merck silica gel 60 F254 plates. Silica gel chromatography was performed using Merck silica gel 
60 (0.063–0.200 mm). HPLC purifications and analyses were carried out using a JASCO PU-2089 
Plus HPLC pump equipped with a JASCO BS-997-01 UV detector. CD experiments were 
performed on a JASCO 715 spectropolarimeter equipped with a PTC-348 temperature controller. 
UV experiments were performed on a JASCO V-530 spectrophotometer, equipped with a PTC-348 
temperature controller. High-resolution ESI-MS analyses were performed on a Thermo LTQ 
Orbitrap XL mass spectrometer (Thermo-Fisher, San Josè, CA, USA). The spectra were recorded 
by infusion into the ESI (Thermo-Fisher, San Josè, CA, USA) source using MeOH as solvent. 1H 
(500 MHz and 400 MHz) and 13C (125 MHz) NMR spectra were recorded on a Agilent INOVA 
spectrometer (Agilent Technology, Cernusco sul Naviglio, Italy); chemical shifts were referenced to 
the residual solvent signal (CHD2OD: δH = 3.31, δC = 49.0; C6D5N: δH = 7.19, 7.55 and 8.71 ppm). 
For an accurate measurement of the coupling constants, the one-dimensional 1H NMR spectra were 
transformed at 64 K points (digital resolution: 0.09 Hz). 1H connectivities were determined by 
COSY and TOCSY (mixing time 100 ms) experiments. Through-space 1H connectivities were 
evidenced using a ROESY experiment with a mixing time of 500 ms. Two and three bond 1H-13C 
connectivities were determined by gradient 2D HMBC experiments optimized for a 2,3 J of 8 Hz. 
3JH-H values were extracted from 1D 1H NMR.  
 
Synthesis of 1a, 1b, 1RR e 1RS 
R or S 3-(4-nitrophenoxy)propane-1,2-diol (2). A mixture of 1, (0.500 g, 3,6 mmol), KOH (1 mg, 
1,8x10-2 mmol, dissolved in 50 μL of EtOH) and dry toluene (2 mL) was stirred under reflux in a 
double neck flask. After 30 min, the mixture was cooled to r.t. and 287 µL of R or S glycidol (0,320 
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g, 4,3 mmol) were slowly added by a syringe. The mixture was further stirred at 90 °C for 24 h. The 
solvent was then evaporated under vacuo and the residue re-dissolved in MeOH. The obtained 
solution was embedded on silica and then rotary evaporated to dryness. The resulting powder was 
applied on a Ethyl acetate: Acetone 70:30 (v/v) packed silica gel column and then eluted using 
isocratic conditions. The fractions containing the desired product were dried under vacuo to give 
0,58 g of 2 as R or S stereomer as a yellow gel (yields 85%). TLC plate Rf. 0,73 (Ethyl acetate: 
Acetone 70:30 (v/v)).  
1H NMR (CD3OD) : 3.64–3.73 (m, 2H, CH2OH), 3.97-4.05 (m, 1H, CHOH), 4.09 (dd, J = 6.1, 9.8 
Hz, 1H, OCH2), 4.18 (dd, J = 4.1, 9.8 Hz, 1H, OCH2), 7.05–7.10 (m, 2H, C2,6ArH), 8.14–8.20 (m, 
2H, C3,5ArH). 
13C NMR (CD3OD) : 63.9 (CH2OH), 71.2 (CHO), 71.4 (CH2O), 115.8 (C2,6Ar), 126.8 
(C3,5Ar), 142.8 (C
4
Ar), 165.5 (C
1
Ar). HRESIMS (positive ion mode, CH3OH) m/z 236.0533 [M+Na]
+ 
(calcd for C9H11NO5Na, 236.0529). 
[α]25 R= -17.8 [c= 12.4 mg/mL; EtOH] S=+16.9 [c=19.2 mg/mL; EtOH]  
In order to quantify the stereo specificity of the reaction, HPLC chromatography on chiral column 
was performed. On the basis of previous reported data [20] we analyzed each single R or S 3-(4-
nitrophenoxy)propane-1,2-diol and a mixture of both species on HPLC by means of ChiralpaK 1A 
column (4,6x 250 mm, particle size: 5 micron) eluted with 90:10 n-exane:propan-2-ol.R- 3-(4-
nitrophenoxy)propane-1,2-diol RT=33,85 min and S 3-(4-nitrophenoxy)propane-1,2-diol 38.55 min. 
The obtained chromatograms were reported in figure 25. 
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Figure 25. A and B. HPLC chromatograms of (R) - and (S) 3-(4-nitrophenoxy)propane-1,2-diol (2) on chiral column ChiralpaK 1A 
eluted with n-hexane:propan-2-ol. C. Overlay of the two chromatograms. D. Mixture of the two stereomers. 
 
S or R 3-(4-aminophenoxy)propane-1,2-diol (3). A mixture of 2 (R or S, 0, 560 g, 2,6 mmol), 
Pd/C (5% w/w respect to 2, 28 mg) and 25 mL di EtOH (90%, HPLC grade) was stirred in a Parr 
apparatus under hydrogen atmosphere (P= 400 psi). After 1.5 -2.0 h the reaction was monitored by 
disappearance of UV band of 2 on TLC plate (Rf. 0.73, Ethyl acetate: Acetone 70:30 (v/v) and the 
C 
D 
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appearance of an UV band also strongly sensitive to ninhydrin (Rf 0.46). The mixture was filtered 
on paper, and the eluted solution dried on vacuo, to obtain 3 as brick-red solid. 3 was further 
purified by crystallization from DCM:MeOH 7:3 (0,440 g, yields 93%) 
NMR (CD3OD) : 3.62 (dd, J = 5.4, 11.2 Hz, 1H, CH2OH), 3.67 (dd, J = 4.8, 11.2 Hz, 1H, 
CH2OH), 3.89–3.84 (m, 1H, CHOH), 3.91 (dd, J = 5.1, 9.8 Hz, 1H, OCH2), 3.95 (dd, J = 4.1, 9.8 
Hz, 1H, OCH2), 6.70 (d, J = 8.8 Hz, 2H, C
2,6
ArH), 6.76 (d, J = 8.8 Hz, 2H, C
3,5
ArH). 
13C NMR 
(CD3OD) : 64.3 (CH2OH), 71.1 (CHO), 71.9 (CH2O), 118.1 (C2,6Ar), 116.6 (C3,5Ar), 141.8 (C4Ar), 
153.6 (C1Ar). HRESIMS (positive ion mode, CH3OH) m/z 184.0980 [M+H]
+ (calcd for C9H14NO3, 
184.0974). 
 
1a, 1b, 1RR and 1RS. 
A mixture of 3 (0,400 g, 2,2 mmol), 205 µL fluoroboric acid (water solution, 48%,3,3 mmol) 4 mL 
of EtOH was cooled to -15°C under argon and then 224 µL of isoamyl nitrite ( 0,258 g, 2,2 mmol) 
were added. After 12h under stirring, the produced diazonium salt was first precipitated diluting the 
mixture with n-hexane, and then further washed with n-hexane (three times). The solid residue was 
dried under vacuo to give 4, which was used in the next step without further treatment. 4 (0,360 g, 
1,8 mmol) was dissolved in 10 mL of acetic acid (14g, 232 mmol), under stirring. Sodium acetate 
(4,0 g, 511mmol) and rac-5 or 5R or S (254 µL, 0,270 g, 2,2 mmol) were added, consecutively, to 
the solution. After 15 min at r.t., the formation of a gel-like mixture was observed. The reaction 
time was further prolonged up to 1 h, under slow stirring. The final mixture was diluted with water 
and extracted with DCM (4-5 times). The collected organic layers were dried under vacuo and the 
residue re-dissolved in MeOH. The obtained solution was embedded on silica and then rotary 
evaporated to dryness. The resulting powder was applied on a DCM: propan-2-ol 90:10 (v/v) 
packed silica gel column and then chromatographed using isocratic conditions. The collected 
fractions, dried under vacuo (TLC 90:10 DCM:MeOH, v/v, Rf=0.6) was further purified on HPLC 
RP-18 column (water:acetonitrile,80:20, v/v, RT= 12 min), to get 0.185 of 1b (yields 51%), 0.210 g 
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of 1a ( yields 58%),0.214 gof 1RR or 1RS (yields 59%). In view of the equivalence in proton and 
carbon resonances of the four species, the following NMR are one time reported, whereas the NMR 
spectra of each species are attached at the end of section. 
1H NMR: NMR (CD3OD) : 3.66 (m, 2H, CH2OH), 3.67 (s, 3H, OCH3), 3.99 (m, 1H, CHOH), 4.13 
(dd, J = 4.2, 9.6 Hz, 1H, OCH2), 4.19 (dd, J = 6.8, 11.7 Hz, 1H, CH2OH), 4.24 (dd, J = 4.7, 11.7 Hz, 
1H, CH2OHpyr), 4.24 (dd, J = 6.0, 9.6 Hz, 1H, OCH2), 5.62 (dd, J = 4.8, 6.6 Hz, 1H, CHCOCH3), 
6.32 (dd, J = 3.0, 3.38 Hz, 1H, C4pyr), 6.67 (dd, J = 1.2, 3.9 Hz, 1H, C
3
pyr), 7.04 (d, J = 8.9 Hz, 2H, 
C2,6ArH), 7.28 (s, 1H, C
5
pyr), 7.70 (d, J = 8.9 Hz, 2H, C
3,5
ArH). 
13C NMR (CD3OD) : 51.8 (OCH3), 
60.2 (CHCOCH3), 62.8 (CH2OH), 70.5 (CHOH), 69.5 (OCH2), 69.4 (CH2OH), 99.9 (C
3
pyr), 110.0 
(C4pyr), 126.2 (C
5
pyr), 147.8 (C
2
pyr), 114.7 (C
2,6
Ar), 123.4 (C
3,5
Ar), 145.5 (C
4
Ar), 160.7 (C
1
Ar), 170.2 
(COCH3).  
HRESIMS (positive ion mode, CH3OH) 1a m/z 364.1510 [M+H]
+; 1b m/z 364.1498 [M+H]+; 1RR 
m/z 364.1498 [M+H]+ 1RS m/z 364.1498 [M+H]+ (calcd for C17H22N3O6, 364.1503).  
UV experiments 
In order to obtain data related to the trans isomer, the cuvette (0.1 o.l. Vol. 400 μL) containing 40 or 
80 μM of 1a or 1b in MeOH was taken in dark at r.t. for about 12 h. UV spectra of the cis isomers 
were acquired after irradiation of the samples with light at 400 or 435 nm (1 min, 1 LED 400 or 
435, Roithner Lasertechnik). The cis thermal decay was monitored by further sequential acquisition 
of spectra until the UV profile rice to that of the initial trans isomer. In order to obtain t1/2 of cis 
isomer, after the sample irradiation with light at 400 or 435 nm, UV time course measurement 
experiments were performed monitoring the absorbance values at 340, 390, 425, 400 and 505 nm, 
number of cycle 100-180, cycle time 60 sec.  
The spectra showing the cis→ trans photo-conversion were obtained after irradiation with green 
light (1 min, 1 LED 505 nm). Finally, the stability of 1a or 1b under the used light conditions, were 
verified acquiring spectra after 12 h of irradiations using the same pulse-program than that 
programmed for biological assay. In particular, the UV cuvette containing 1a or 1b at 40 mM was 
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exposed to led lamps at 435 or 505 nm. Leds were managed by an Arduino module (50 ms-ON/ 1.0 
min-OFF). 
Cell cultures and treatments  
HCT 116p53-/- cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM), 
supplemented with 10% fetal bovine serum (FBS) (Euroclone S.p.A), 2 mM L-glutamine and 50 
U/ml penicillin-streptomycin, under humidified atmosphere of 5% CO2 at 37°C. Treatments of 
cells were performed replacing the culture medium with those containing indicated compounds at 
final concentration of 1 and 10 μM per well. Cells were subsequently exposed to light irradiation at 
400, 435 or 515 nm for 12h and analyzed by MTT assay. 
MTT assay 
HCT 116p53 -/- cells were seeded onto 96-well plates at density of 2 x 104 cells/well. Cell viability 
was evaluated using the MTT assay procedure, which measures the level of mitochondrial 
dehydrogenase activity of living cells using the yellow 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT) as substrate. The absorbance was measured at 540 nm using a 
microplate reader (Labsystems Multiskan). A pool of three different sets of experiments were 
performed. Error bars represent mean ± SEM from n=3 biological replicates. Statistical analysis 
was performed as previously described. 
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HRESIMS of 1a after 5 days from dissolution in PBS (negative ion mode, CH3OH) 
 
HRESIMS of 1a after 5 days from dissolution in PBS. The spectrum was acquired in negative mode. [C16H18N3O6-] 
calculated 348.1201 uma experimental 348.1187 uma; [C16H17N3NaO6-] calculated 370.1021 uma experimental 370.1005; 
mass fragment [C12H10N3O-••] calculated 212.0829 experimental 212.0823 uma. 
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3. Incorporation of a 4-(dimethylamino)azobenzene moiety into G-quadruplex 
aptamers 
 
3.1. Introduction 
A molecular nano-machine may be described as a molecular nanostructure, performed by the self-
assembly of monomers, that, upon external stimuli, undergoes some structural changes amounted to 
mechanical movements (temperature, pH value, electrical-field strength, molecular recognition, 
etc.) [21]. Stimulation by light is the most promising compared to chemical (or electrochemical) 
stimuli [22]. Indeed, as above discussed, modulating either the wavelength or the intensity of light 
high level of spatiotemporal control can be achieved. 
Structured DNA is a good candidate as molecular-level machine in view of its self-assembly 
properties [23]. Moreover, DNA is characterized by high structural polymorphism allowing to 
potentially expand the number of achievable nano-machines [24]. Among the possible DNA 
structures, G-Quadruplexes (GQ) are of great interest because of their well-defined and stable 
conformations.  
Pioneering work about a G-quadruplex nano-machine was reported by Mergny and co-workers 
[25]. Starting from a single 21-base oligonucleotide, folded into a G-quadruplex, the sequential 
addition of two complementary single stranded oligonucleotides generated a quadruplex–duplex 
reversible equilibrium that released a DNA duplex as side product. Recently, Ogasawara and Maeda 
[26] described for the first time a method for the reversible photo-regulation of G quadruplex 
structures. In particular, 8-fluorenylvinyl-2’-deoxyguanosine (8FVG, figure 26), was incorporated in 
the G-quadruplex. After irradiation 8FVG undergoes to trans→cis photo-isomerization causing the 
reversible disruption of the G-quadruplex.  
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Figure 26. Photo-induced cis–trans isomerization of 8-fluorenylvinyl-2’-deoxyguanosine (8FVG)[from Angew. Chemie-Int. Ed., vol. 
48, no. 36, pp. 6671–6674, 2009]. 
 
Furthermore, Wang and co-workers through the use of azobenzene derivative reported in figure 27 
provoked, by photo-irradiation, the reversible stretching and folding of the d-(TTAGGG)4 G-Q. The 
trans azobenzene moiety induced the folding of the sequence into GQ, whereas the cis azobenzene 
moiety caused the disruption of the folded GQ (Figure 27) [27].  
 
Figure 27. Reversible folding and stretching of the of the d-(TTAGGG)4G quadruplex through the trans-cis photoisomerization of 
the azobenzene moiety [from Angew. Chem. Int. Ed. 2010, 49, 5305 –5309]. 
In this frame, the photo-control of GQ forming aptamers, endowed with pharmacological activities, 
should be of interest. Given that specific conformations of the folded GQ are the key elements for 
the binding of aptamers to their targets, the photo-regulation of the aptamer GQ conformations 
could be used both to control their biological action and to develop new potential nano-machines.  
In this frame, recently I started a research project concerning the synthesis and the structural 
characterization of azobenzene-conjugated GQs. In order to reach this goal, firstly I synthesized the 
4-(dimethylamino)azobenzene derivative (4-DMAzo R) reported in figure 28. Trans-cis photo- 
isomerisation of 4-(dimethylamino)azobenzene (4-DMAzo R) can be induced by violet light, 
suitable to be used on DNA systems. Furthermore, the two hydroxyl groups of the glycerol linker 
inserted on one benzene ring are useful to convert the azobenzene derivative into the appropriate 
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phosphoramidite building block. The latter molecule was used to obtain, by means of automated 
DNA synthesizer, TBA and T30695 GQs conjugated at 5'end with 4-DMAzo R.  
O
OH
OHN
NN
 
5 
Figure 28. (R)-3-(4-((4-(dimethylamino)phenyl)diazenyl)phenoxy)propane-1,2-diol (4-DMAzo R). 
 
First of all, I started to evaluate the photo-responsive properties of the new 4-DMAzo-R, which are 
particularly distinctive compared to other azobenzene compounds, as previously reported in 
literature [28][29]. Starting from these results, I explored the behaviour of the free 4-DMAzo R 
(Figure 28) and of 5'-DMAzo-TBA or 5'-DMAzo-T30695 (Table 1) in different solvent condition. 
 
3.2. Results and discussion 
Synthesis of Phosphoramidite Monomer 7R 
The synthesis the 4-DMAzo moiety is shown in Figure 29. 
The four synthetic steps were performed starting from 4-nitrophenol (Figure 29), which was 
coupled with R glycidol in presence of catalytic amount of KOH, to obtain the intermediates 2 [20]. 
Reduction of 2, as R stereomer, with H2/Pd (C) and successive conversion of the amino- to the 
diazonium-group gave rise to 4R, which was finally coupled with N,N-dimethylaniline 5. 
According to the above reported synthesis of 1a (see page 83), the best yields of the coupling step 
were obtained quenching the reactions after 1h from the mixture gelification. 
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Figure 29. Synthesis of 4-DMAzo R moiety. a) 1, (0.500 g, 3,6 mmol), KOH (1 mg, 1,8x10-2 mmol) and dry toluene (2 mL); b) 2 (R, 
0, 560 g, 2,6 mmol), Pd/C (5% w/w respect to 2, 28 mg) and 25 mL di EtOH; c) 3 (0,400 g, 2,2 mmol), 205 µL fluoroboric acid 
(water solution, 48%,3,3 mmol ) 4 mL of EtOH (-15°C), isoamyl nitrite ( 0,258 g, 2,2 mmol); d)4 (0,360 g, 1,8 mmol) was dissolved 
in 10 mL of acetic acid (14g, 232 mmol), sodium acetate (4,0 g, 511mmol) and N,N-dimethylaniline (254 µL, 0,270 g, 2,2 mmol). 
Percentage yield: 59% 
The synthesis of phosphoramidite monomer 7R (Figure 30) started from the 4-
(dimethylamino)azobenzene moiety (5R) that was subjected to the standard protection of one 
alcoholic function with 4,4′-dimethoxytrityl group. The protected product 6R was then reacted with 
β-cyanoethyl-N,N’-diisopropyl-chloro-phosphoramidite to obtain 7R. This monomer was used to 
automatically synthesize the modified ONs reported in Table 1 using the standard phosphoramidite 
protocol (see part I). The yields of coupling were similar to those obtained using the standard 
phosphoramidite building blocks. 
 
 
Figure 30. Synthesis of phosphoramidite monomer 7R. e) 5R (0.400 g, 1.3 mmol), 4,4-dimethoxytrityl chloride (0.430 g, 1.3 mmol), 
4-dimethylaminopyridine (0.0076 g, 0.062 mmol) dry Py (6.35 ml), 2.5 h, yields 44%; f) 6R (0.350 g, 0.57 mmol),β-cyanoethyl-
N,N’-diisopropyl-chloro-phosphoramidite (0.190 ml, 0.85mmol), DIPEA (0.296 ml, 1.7 mmol), dry DCM (3 ml), 1.0 h. 70%. 
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Table 1. 
ON Sequence 
T30695  5’-GGGTGGGTGGGTGGGT-3’ 
5’-DMAzoR-T30695  5’-DMAzo R-GGGTGGGTGGGTGGGT-3’ 
TBA 5’-GGTTGGTGTGGTTGG-3’ 
5’-DMAzoR-TBA  5’-DMAzo R-GGTTGGTGTGGTTGG-3’ 
 
UV/Vis spectra of 5R 
The rate of thermal relaxation of the cis-4-DMAzo is strongly dependent on solvent polarity and on 
the pH of the solutions. Indeed, cis to trans thermal decay of 4-DMAzo compounds increases with 
the increasing of either the solvent polarity or the proton concentration in the solution [28][29]. 
Sanchez and co-workers reported the dependence of the rate of cis →trans conversion from the 
concentration of hydroxide ions in the solution. Similarly, the cis-trans isomerization can be 
accelerated by small traces of acids [30]. 
Successive studies suggested a plausible mechanism concerning the pH influence on the half-life of 
certain functionalized 4-DMAzo cis isomers (Figure 31) [31]. 
 
Figure 31. Schematic representation of cis-trans equilibria. The constants rate k4 and k5 are lower than k6, consequently the 
conversion rate is mainly dependent on the thermal conversion of the cis-azonium [from J. Org. Chem, vol. 64, no. 17, pp. 1604–
1609, 1999]. 
In the opinion of those authors, the acid/base-assisted tautomerization of cis ammonium ions into 
cis-azonium ions could cause the catalytic effect on thermal decay of the cis form. Indeed, cis-
127 
 
azonium ions could easily isomerize via rotation around the -N=N- bond as a result of the 
concomitant decrease in the double bond character. In addition, the solvent can also affect the 
thermal conversion rates of the cis amino-benzene derivatives, indeed this cis to trans conversion 
could be accelerated in protic solvents [32]. 
Confirming these findings, the UV spectra of cis 5R obtained using water or methanol, or different 
H2O/ACN mixtures, could not be evidenced by means of a conventional UV-Vis 
spectrophotometer, in view of the extremely fast cis→ trans conversion (Figure 32). These results 
evidenced that the presence of glycerol linker on one benzene ring of 5R did not significantly affect 
the general behaviour of the 4-DMAzo.  
 
 
Figure 32. UV spectra of the 5R before (green) and after (blu) irradiation with 400 or 435 nm led, in CH3OH (A) and in H2O / ACN 
(B). 
A 
B 
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In order to decrease the cis→trans thermal decay, UV-Vis spectroscopy experiments of 5R (131 
μM) were carried out in H2O/ACN solution 60:40 (v:v) in the presence of growing concentrations 
of an organic base, triethylamine (TEA) (Table 2). 
                                        Table 2 
5R 
(μM) 
TEA 
(μM) 
Ratio 
(5R/TEA) 
131 131 1:1 
131 1310 1:10 
131 1965 1:15 
131 3275 1:25 
131 6550 1:50 
131 13100 1:100 
131 32750 1:250 
131 65500 1:500 
131 98250 1:750 
131 131x103 1:1000 
131 131x104 1:10000 
 
 
Figure 33. UV-Vis spectra of 5R (131μM) in H2O/ACN 60:40 (v:v); A) 5R:TEA (1:1), B) 5R:TEA (1:10), C) 5R:TEA (1:15). 
 
A slight decrease of the cis-trans conversion rate was observed at the ratio 5R:TEA (1:15) (Figure 
33 C), increasing the TEA concentration a significant decreasing in the rate of cis→trans thermal 
decay was obtained. In particular, starting from the ratio 5R:TEA (1:25) it was possible to monitor 
the thermal decay by sequential acquisition of spectra until reaching the initial trans isomer UV 
profile (Figure 34 1-8). 
 
 
A B C 
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1) 5R : TEA=1:25 in H2O:Acn (6:4) 
 
 
 
 
2) 5R : TEA=1:50 in H2O:Acn (6:4) 
 
 
 
3) 5R : TEA=1:100 in H2O:Acn (6:4) 
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4) 5R : TEA=1:250 in H2O:Acn (6:4) 
 
 
 
5) 5R : TEA=1:500 in H2O:Acn (6:4) 
 
 
 
 
6) 5R : TEA=1:750 in H2O:Acn (6:4) 
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7) 5R : TEA=1:1000 in H2O:Acn (6:4) 
 
 
8) 5R : TEA=1:10000 in H2O:Acn (6:4) 
 
Figure 34. UV spectra of trans (green) and cis (blu) 5R in H2O / ACN (6:4) at different ratio 5R:TEA (1:25, 1:50, 1: 100, 1: 250, 1: 
500 , 1: 750, 1: 1000, 1: 10000). In all these conditions, the thermal decay was monitored by sequential acquisition of spectra until 
the UV profile rice to that of the initial trans isomer. Cell length: 0.1 cm. 
 
In order to measure the t1/2 of metastable cis isomer, obtained after irradiation at 435 nm, UV time 
course measurement experiments were performed monitoring the absorbance values at 416, 448, 
525, 260 nm (number of cycle 100-180, cycle time 60 sec). In figure 35 the kinetics were all 
reported at 416 nm. The t1/2 values were calculated from the resulting calibration curve fit equation, 
these results are shown in Table 3. 
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Table 3. t1/2 values of cis 4-DMAzo R (5R,131µM) at different ratio of TEA. 
 
 
 
 
 
 
 
 
5R:TEA=1:50 in H2O:Acn (6:4) 
 
 
5R:TEA=1:100 in H2O:Acn (6:4) 
 
  
5R:TEA t½ (s) ± standard error 
1:15 <75 ± 15  
1:50        74 ± 14 
1:100        84 ± 6 
1:250      219 ± 34 
1.500   200,5 ± 4,5 
1:750      294 ± 7 
1:1000      555 ± 145 
1.10000      467 ± 50 
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5R:TEA=1:250 in H2O:Acn (6:4) 
 
 
5R:TEA=1:500 in H2O:Acn (6:4) 
 
 
5R:TEA=1:750 in H2O:Acn (6:4) 
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5R:TEA=1:1000 in H2O:Acn (6:4) 
 
 
5R:TEA=1:10000 in H2O:Acn (6:4) 
 
Figure 35. Time-dependent absorption of 5R after irradiation in H2O / ACN (6:4) at wavelength 416 nm in presence of different equivalents of 
TEA (5R:TEA= 1:50; 1: 100; 1: 250; 1: 500; 1: 750; 1: 1000; 1:10000). All curves were obtained by using the "fixed wavelength" 
application. 
 
 
From these results it appears that TEA can extend the cis half-life. Particularly, increasing the 
concentration of TEA from 100 to 750 equivalents (respect to 1 equivalent of 5R) a strong 
decreasing of the rate of cis 5R thermal relaxation decay was observed. The highest half-life value 
was obtained for a ratio 5R: TEA of 1: 1000 (Table 3). Further increasing of the base concentration 
did not change the t1/2 of cis to trans conversion (Figure 36).  
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Figure 36. Cis half-life dependent on base concentration (TEA). 
 
Considering the highest cis half-life obtained with 1:1000 (5R: TEA), I also evaluated the effect of 
DIPEA on the cis-trans isomerization rate at the same concentration. As showed in figure 37, also 
the DIPEA was able to decrease the rate of the cis 5R thermal relaxation. 
5R : DIPEA = 1:1000 in H2O:Acn (6:4) 
 
Figure 37. UV spectra of trans (green) and cis (blu) 5R in H2O/ACN (6: 4) at a ratio 5R:DIPEA (1: 1000). The thermal decay was 
monitored by sequential acquisition of spectra until the UV profile rice to that of the initial trans isomer. 
 
 
 
Finally, I considered also the effect of an inorganic base, NaOH, on cis-trans thermal relaxation rate 
of 5R. Once again, the base was able to increase the half-life of the cis form (Figure 38). 
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5R: NaOH = (1:1000) in H2O/ACN (7:3) 
 
 
Figure 38. UV spectra of trans (green) and cis (blu) 5R in H2O / ACN (7:3) at a ratio 5R: NaOH (1:1000). The cis thermal decay was 
monitored by sequential acquisition of spectra until the UV profile raised that of the initial trans isomer. 
 
 
Owing to the poor solubility of 5R in the used solvents, I performed UV absorbance measurements 
at different concentrations of 5R (Figure 39). 
 
 
Figure 39. Dependence of UV absorbance measured at 408nm on 5R concentration in H2O:ACN (6:4). 
 
As shown in the figure 39, using the mixture H2O:ACN (6:4) as solvent, a linear dependence of the 
absorbance measured at 408 nm on 5R concentration was observed only in the range of 0.05-0.2 
mM. The most significant deviation from linearity were obtained increasing the concentration over 
than 0.35 mM. This value was strongly similar (131µM) to that used in our experiments to evaluate 
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the rate of thermal decay of cis 5R. In view of these results, specific phenomena associated with 
molecular aggregation on the half-life time of cis 5R could be excluded. 
Fast spectroscopy experiments 
 
In order to quantify the fast thermal relaxation rate in dark of cis isomer in methanol, UV fast 
spectroscopy experiments were conducted in collaboration with Professor Carlo Altucci 
(Department of Physic, University of Studies Federico II, Naples) (for the description see paragraph 
2.2) 5R was dissolved in methanol and was irradiated with a laser beam focused at different 
wavelengths; at the same time fluorescence measurements of the sample were performed. In these 
experiments a weak fluorescence, whose decay was in the range of nanoseconds, was observed 
when the solution was irradiated at 312 nm with fluorescence bands in emission of 342 and 372 nm 
(Figure 40). Therefore, in methanol cis-trans conversion of 5R proceeds with relaxation times in the 
range of nanoseconds, confirming our previous observation on the basis of the UV measurements.  
 
Figure 40. Fluorescence intensity dependence on time, after irradiation at 312 nm. 
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Structural characterization of conjugated oligonucleotides (5'-DMAzo-T30695 and 5'-
DMAzo-TBA) 
UV-vis spectra 
UV-vis spectra of conjugated oligonucleotides (5’-DMAzo-T30695 and 5’-DMAzo-TBA) showed 
two bands, at 258 and 450 nm (Figures 41 and 42). The first one is centred at 258 nm and 
corresponded to the DNA absorption band. The latter, that was absent in the UV spectrum of the 
unmodified sequences should correspond to that of conjugated chromophore.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 41. (A) T30695 (black) and 5'-DMAzo-T30695 (red) 20µM in K+ buffer (10 mM potassium phosphate, 10 mM KCl, 
pH=7.4). Cell length 0.5 cm (B) Enlargement of the range 350-550 nm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. (A) UV spectra of TBA (black) and 5'-DMAzo-TBA (red) 20µM in K+ buffer (10 mM potassium phosphate, 90 mM KCl, 
pH=7.4). Cell length 0.5 cm. (B) Enlargement of the range 350-550nm.  
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CD and CD melting  
In order to evaluate the effects of the 4-(dimethylamino)azobenzene on the ability of the conjugated 
sequences to fold into G-quadruplexes, I performed CD spectra in K+ buffer (Figure 43 A-B) From 
the collected data it appeared that 5'-DMAzo-TBA and 5'-DMAzo-T30695 are able to fold into G-
quadruplex structures very similar to the corresponding unmodified oligonucleotides. Indeed, 
similarly to the unmodified TBA, the CD profile of 5'-DMAzo-TBA is characterized by three 
positive bands at 212, 247 and 295 nm and a negative band around 270 nm that can be attribute to 
the presence in the solutions of an antiparallel G-quadruplex (Figure 43A). Correspondingly, also 
the CD profiles of T30695 and of 5'-DMAzo-T30695 are characterized by three positive CD bands 
at about 209, 262 and 303 nm and one negative CD band at 242 nm, thus suggesting that the 
conjugated sequence preserved the same ability of T30695 to fold into parallel a G4 structure. 
(Figure 43B). 
 
 
 
 
Figure 43. (A) CD profiles of TBA (black) and 5’-DMAzo-TBA (red) 20µM in K+ buffer (10 mM potassium phosphate, 10 mM 
KCl, pH=7.4); (B) CD profiles of T30695 (black) and 5’-DMAzo-T30695 (red) 20µM in K+ buffer (10 mM potassium 
phosphate, 90 mM KCl, pH=7.4). Cell length: 0.5 cm.  
 
 
CD melting studies were also performed in order to evaluate the effects of the conjugated 
azocompound on GQs stabilities (Figures 44-45).  
The melting curve of 5'-DMAzo-TBA was registered monitoring the change of the intensity of 
the band at 295 nm increasing the temperature from 10°C to 90°C in K+ buffer. Figure 44 shows 
the two obtained CD melting profiles for TBA (black) and for 5'-DMAzo TBA (red). It appears 
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that the conjugation with the azobenzene moiety significantly reduced the thermal stability of 
TBA G4 structure (ΔTm∼6°C). 
 
Figure 44. CD melting profiles of TBA (black) and 5’-DMazo-TBA (red). Fixed wavelength 295 nm. [ON] of 2.0×10-5 M. in K+ 
buffer (10 mM potassium phosphate, 10 mM KCl, pH=7.4). Temperature scan speed 0.2°C/min. Cell length 0.5 cm. 
 
 
Two CD melting profiles for the 5'-DMAzo-T30695 were obtained, using two different buffered 
solutions, containing K+ or Na+ cations. In both cases the experiments were performed monitoring 
the change of the intensity of the band at 263 nm increasing the temperature from 10°C to 100°C. 
Similarly to T30695 (see also part I paragraph 3.2), the CD melting curve of 5'-DMAzo-T30695 
showed two inflection points suggesting that two unfolding events (5'-5' end-to-end stacked dimeric 
GQs→ GQs monomers → unfolded single strands) occurred in the solutions (Figure 45 A-B). 
Although 5'-DMAzo-T30695 showed a thermal stability higher than T30695 both in Na+ and in K+ 
buffer, the two profiles were quite different; particularly in K+ buffer the monitored CD band 
appeared to persist also at 100 °C, thus suggesting that the corresponding G-quadruplex should yet 
be in the solution at the highest explored temperature.  
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Figure 45. CD melting profiles of T30695 (black) and 5’-DMazo-T30695 (red). Fixed wavelength 263 nm. [ON] of 2.0×10-5 M. Cell 
length 0.5 cm. Temperature scan speed 0.2°C/min. (A) K+ buffer (10 mM potassium phosphate, 90 mM KCl, pH=7.4); (B) Na+ buffer 
(10 mM sodium phosphate buffer, 60 mM NaCl, pH=7.4). 
 
Photo-responsivity of 4-(dimethylamino) azobenzene derivative conjugated to TBA and 
T30695 
In order to verify the effect of the cis-trans photoisomerisation of the 4-(dimethylamino) 
azobenzene moiety on the 5'-end of TBA and of T30695 G-quadruplex structures, it was 
appropriate to investigate the right conditions both to enable a slow cis to trans thermal relaxation 
time of cis form, and to preserve the oligonucleotides integrity. As described above, the cis 5R half-
life could be increased by a certain concentration of triethylamine, starting from the ratio 5R: TEA 
(1:25) a substantial cis half-life increasing was obtained by allowing to monitor the thermal decay 
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by a conventional UV-Vis spectrophotometer. In view of this fact, I chose the minimum 
concentration of TEA with the aim of reducing substantially the cis thermal relaxation rate without 
affecting the oligonucleotides stability.  
Due to the poor solubility of the triethylamine in the aqueous solutions suited for the 
oligonucleotides, it was necessary to add an organic solvent. Literature data showed that ethanol 
should stabilize the G-quadruplex structure [33]. On this basis, I chose to explore the behavior of 
5R in a mixture H2O:EtOH (1:1).  
First of all, I verified that 5R proceeded to photo-isomerization in these conditions: H2O:EtOH=1:1, 
5R:TEA 1:25 and 20mM KCl; t1/2:0.72 (Figures 46-47) 
 
5R [75 M]
f = y0+a*(1-exp(-b*x))
time (min)
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0.20
Parameter	Value	StdErr	CV(%)	Dependencies
y0	 2.711e-2	 7.639e-3	 2.818e+1	 0.9995256
a	 1.504e-1	 7.613e-3	 5.063e+0	 0.9995110
b	 9.556e-1	 4.098e-2	 4.288e+0	 0.8777894
t1/2=0.72 min= 43 sec
 
Figure 46. Time-dependent absorption of 5R after irradiation in H2O/EtOH (1:1) at wavelength 416 nm in presence of TEA 
(5R:TEA= 1:25). 
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Figure 47. UV spectra of trans (green) and cis (blue) 5R in H2O/EtOH (1:1) at a ratio 5R:TEA (1:25), 20mM KCl. Cell length: 0.1 
cm. 
 
In addition, CD and CD melting data showed that 5'-DMAzo-TBA and 5'-DMAzo-T30695 
preserved the G-quadruplex structures in the used conditions.  
The CD spectra in H2O : EtOH (1:1) and with a ratio of oligonucleotides: TEA (1:25) kept the same 
profiles compared to that obtained in K+ buffer, above reported (Figure 43). 
To better compare the two different conditions for each oligonucleotide, the CD spectra were 
reported in molar ellipticity (Figure 48).  
 
 
Figure 48. CD profiles: (A) 20µM of 5'-DMAzo-T30695 (green) in K+ buffer (10 mM potassium phosphate, 90 mM KCl, 
pH=7.4), cell length 0.5 cm; 3.5 µM of 5'-DMAzo-T30695 (blue) in H2O / EtOH (1: 1), ON:TEA (1:25), 20mM KCl, cell length 
0.5 cm. (B) 20µM of 5'-DMAzo-TBA (green) in K+ buffer (10 mM potassium phosphate, 90 mM KCl, pH=7.4), cell length 0.5 
cm; 3.5 µM of 5'-DMAzo-TBA (blue) in H2O / EtOH (1: 1), ON : TEA (1:25), 20mM KCl, cell length 0.5 cm.  
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As concerning the CD melting curves, the G4 structure of 5'-DMAzo-TBA and 5'-DMAzo-T30695 
preserved also a certain stability (Tm 5’-DMAzo-TBA∼ 57°C, Tm of 5'-DMAzo-T30695 was not 
detectable in view of the persistence of the CD band at 263 nm also at the highest explored 
temperature) (Figures 49-50). 
 
Figure 49. CD melting curve of 5’-DMAzoTBA in H2O / EtOH (1: 1), [ON] = 3.5x10-6M; ON : TEA (1:25), 20mM KCl. Cell length 
0.5 cm. Scan speed= 0.2°C/min.  
 
 
Figure 50. CD melting curve of 5’-DMAzo T30695 in H2O / EtOH (1: 1), [ON] = 3.5x10-6M; ON : TEA (1:25), 20mM KCl. Cell 
length 0.5 cm. Scan speed= 0.2°C/min. 
 
Based on the described results it should be considered that the solvent conditions used for the 
experiments and the presence of the organic base in the solutions did not affect the ability of 5'-
DMAzo-T30695 and 5'-DMAzo-TBA to fold into G4. In order to study the effects of the photo-
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isomerization of the conjugated chromophore on the stability and/or typology of the TBA- or 
T30695-G4 structures these solutions were successively irradiated at 435 nm.  
UV-Vis spectra of 5'-DMAzo-TBA and 5'-DMAzo-T30695 were performed before and after 
irradiation by LED light at 435 nm (Figures 51-52). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 51. UV spectra of 5'-DMAzo-TBA before irradiation at 435 nm RED, after irradiation at 435nm BLUE, in H2O/EtOH (1:1), 
[ON] = 3.5x10-6M; ON : TEA (1:25), 20mM KCl. Cell length 0.5cm. (A) Full spectrum (B) Enlargement 300-550 nm corresponding 
the absorbition band of the 5'-DMAzo moiety. Before and after irradiation a slight changing of this portion of the UV spectrum 
occurred (Figure B). Time-dependent UV spectra of 5’-DMAzo-TBA after irradiation at 435 nm, UV band of the 5’-DMAzo moiety 
changes during time (C) Full spectrum (D) Enlargement 340-600 nm corresponding the absorbition band of the 5'-DMAzo moiety. 
(E) UV spectra of trans (green) and cis (blue) 5R in H2O / EtOH (1: 1) at a ratio 5R:TEA (1:25), 20mM KCl. Cell length: 0.1 cm. 
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Figure 52. UV spectra of 5'-DMAzo-T30695 before irradiation at 435nm (red) and after irradiation at 435nm (Blue), in H2O/EtOH 
(1:1), [ON] = 3.5x10-6M; ON : TEA (1:25), 20mM KCl. Cell length 0.5cm. (A) Full spectrum (B) Enlargement 300-550 nm 
corresponding the absorbition band of the conjugated 5'-DMAzo moiety. 
 
UV spectra of 5'-DMAzo-T30695 after irradiation did not show substantial changes of the 
absorption band connected to 5'-DMAzo moiety. Slight differences in the region 350-500 nm of the 
UV spectra before and after irradiation were found in the case of 5'-DMAzo-TBA.  
Our results are in contrast with previous results reported by Kamei and co-workers concerning the 
cis to trans photoisomerization of an analogue of 4-DMAzo conjugated at DNA double helices. In 
that case, the use of aqueous basic solution stabilized the cis form of azobenzene analogue 
conjugated at DNA [30]. 
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In order to further explore the effect of the trans →cis photo-isomerization on the G4 structures, 
CD experiments conducted before and after irradiation were also performed.  
 
Figure 53. CD spectra: (A) 5’-DMAzo-TBA before irradiation at 435nm RED, after irradiation at 435nm BLUE, in H2O/EtOH (1:1), 
[ON] = 3.5x10-6M; ON : TEA (1:25), 20mM KCl. (B) 5’-DMAzo-T30695 before irradiation at 435nm RED, after irradiation at 
435nm BLUE, in H2O/EtOH (1: 1), [ON] = 3.5x10-6M; ON : TEA (1:25), 20mM KCl. Cell length 0.5 cm. 
 
The CD profiles of the two modified sequences did not undergo significant variations after 
irradiation (Figure 53). However, considerable differences in the region 350-500 of the CD spectra 
acquired for 5'-DMAzo-TBA and 5'-DMAzo-T30695 were observed. CD bands in this region 
should be attributable to the conjugated chromophore. A Cotton effect centered at 435 nm appeared 
only in the CD profiles of 5'-DMAzo-TBA, thus suggesting that the 5'-conjugated chromophore 
could have different spatial orientation respect to the TBA or T30695 G-quadruplex.  
 
3.3. Conclusion  
In this work we focused on the synthesis of the new azobenzene derivative named 4-DMAzo R 
(Figure 28) and its conjugation at the 5’end of two G-quadruplex forming oligonucleotides, TBA 
and T30695 (Table 1). Firstly, we studied the photo-responsive properties of the 4-DMAzo R after 
irradiation with a LED light at 435 nm in different solvent conditions. From the obtained results, it 
can be deduced that the relaxation thermal rate of cis 4-DMAzo R strongly depends on the polarity 
of the solvent and on protonation of the azo-group, in particular it increases with increasing of 
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either the solvent polarity or the proton concentration in the solution. In basic conditions obtained 
by adding small quantity of TEA, using H2O:EtOH (1:1) as solvent, the cis →trans 4-DMAzo R 
thermal relaxation occurred in the time scale of minutes, that is suitable to be registered by a 
conventional UV-Vis spectrophotometer. However, the photo-responsive properties of 4-DMAzo-
conjugated oligonucleotides, 5’-DMAzo-TBA and 5’-DMAZo-T30695, significantly differ from 
that of free 4-DMAzo R, measured in the same solvent conditions. Notably, also adding TEA to the 
sample, irradiation at 435 nm does not produce changes in the shape and in the intensity of the UV 
bands of 5’-DMAZo-T30695; while slight changes of the adsorption band associated to the 4-
DMAzo moiety are observed in the UV spectra of 5’-DMAzo-TBA. Probably, the 5'-conjugated 
moiety could interact with the folded TBA- or T30695-G-quadruplex structures in different way, 
from which different effects on thermal relaxation rate could be provoked. This hypothesis is, at 
least in part, corroborated by the CD heating experiments that show significant increasing of the 
thermal stability of the 5’-DMAzo-T30695 G-quadruplex, compared to that of T30695; contrarily, it 
appears that the conjugation at 5'-end of TBA negatively affects the thermal stability of the 
corresponding TBA-G-quadruplex. On the basis of these results, in collaboration with the Prof. C. 
Altucci (Department of Physic, University of Studies Federico II, Naples), further studies by means 
of UV fast spectroscopy will be performed, in order to characterize the kinetic of the trans to cis 5’-
DMAzo-TBA and 5’-DMAZo-T30695 photo-conversion. Moreover, we are now synthesizing the 
right quantity of the conjugated oligonucleotides in order to perform 1D and 2D NMR experiments 
useful for the structural characterization of the folded G-quadruplex structures.  
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3.4. Experimental section 
 
General procedure 
General procedure is already described at pages 35, 67, 100. 
 
Synthesis of 5R 
The synthesis of 5R is very similar to that reported for 1a, 1b, 1RR e 1RS (see paragraph 2.3 page 
100), but at the final step N,N-dimethylaniline (254 µL, 0,270 g, 2,2 mmol) was added instead of 
the pyrrole derivative.  
1H NMR (CD3OD) δ: 3.06 (s, 6H, N(CH3)2), 3.67 (m, 2H, CH2OH), 4.00 (m, 1H, CHOH), 4.04 (dd, 
J = 4.2, 9.6 Hz, 1H, OCH2), ), 4.14 (dd, J = 6.0, 9.6 Hz, 1H, OCH2), 6.82 (d, J = 9.1 Hz, 2H, 
C3,5ArH), 7.06 (d, J = 8.9 Hz, 2H, C
2,6
ArH), 7.77 (d, J = 9.1 Hz, 2H, C
2,6
ArH),  7.77 (d, J = 8.9 Hz, 
2H, C3,5ArH).  
13C NMR (CD3OD) δ: 39.3 (N(CH3)2), 62.9 (CH2OH), 70.6 (CHOH), 69.4 (OCH2), 111.5 (C3,5Ar), 
114.6 (C2,6Ar), 123.8 (C
3,5
Ar), 124.3 (C
2,6
Ar), 143.7 (C
1
Ar), 147.7 (C
4
Ar), 152.5 (C
4
Ar), 160.7 (C
1
Ar). 
HRESIMS (modalità positiva, CH3OH) m/z massa trovata 316.1651 [M+H]
+ (calcd for 
C17H22N3O3, 316.1656). 
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R (E)-3-(4-((4-(dimethylamino)phenyl)diazenyl)phenoxy)propane-1,2-diol (5R) 
HRMS (ESI+) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Varra 25_5_2015 Fr18_20 msms316+ #14 RT: 0.22 AV: 1 NL: 7.72E6
T: FTMS + c ESI Full ms2 316.16@cid34.00 [85.00-500.00]
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1H-NMR 
 
 
 
 
 
 
13C-NMR 
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COSY 
 
 
 
HSBC 
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HSQC 
 
 
 
Synthesis of monomer phosphoramidite building block 7R 
5R (0.400 g, 1.3 mmol), 4,4-dimethoxytrityl chloride (0.430 g, 1.3 mmol), 4-
dimethylaminopyridine (0.0076 g, 0.062 mmol) were dissolved in dry Pyridine (6.35 ml). The 
resulting solution was stirred at room temperature (r.t.) under argon for 3 h. The solution was 
concentrated under reduced pressure and the residue purified by column chromatography on silica 
gel (eluted with 50:50:0.1 N hexane/ethyl acetate /Et3N) to give monodimethoxytritylated 6R as a 
clear orange solid (yields 44%).6R (0.350 g, 0.57 mmol),β-cyanoethyl-N,N’-diisopropyl-chloro-
phosphoramidite (0.190 ml, 0.85mmol), DIPEA (0.296 ml, 1.7 mmol) were dissolved in dry DCM 
(3 ml), 1.0 h. 70%. 
After 60 min, the reaction was diluted with ethyl acetate (15 ml), and finally washed with 10% 
sodium carbonate solution (15 ml) and brine (15 ml). The organic layer was dried on magnesium 
sulphate and concentratedin vacuo. The residue was purified by silica gel chromatography eluted 
with hexane/ethyl acetate and triethylamine (80:10:10). The fractions containing the product were 
collected and concentrated under vacuum, yielding 7R as orange foam (85% yield). 
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Synthesis of oligomers 
5’-DMAzo-TBA and 5’-DMAzo-T30695 were synthesized using the standard solid phase DNA 
chemistry similarly to the oligonucleotides reported in the part I adding a coupling stage with the 
7R phosphoramidite building block at the end of the synthesis of the TBA and T30695 sequences, 
and extending the times of the two coupling steps from 2 to 15 minutes. 
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